US20100057201A1 - Prosthetic valve with vessel engaging member - Google Patents
Prosthetic valve with vessel engaging member Download PDFInfo
- Publication number
- US20100057201A1 US20100057201A1 US12/616,518 US61651809A US2010057201A1 US 20100057201 A1 US20100057201 A1 US 20100057201A1 US 61651809 A US61651809 A US 61651809A US 2010057201 A1 US2010057201 A1 US 2010057201A1
- Authority
- US
- United States
- Prior art keywords
- vessel engaging
- medical device
- vessel
- valve
- main body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2475—Venous valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/0078—Quadric-shaped hyperboloidal
Definitions
- the present invention relates to medical devices. More particularly, the invention relates to medical devices for implantation in a body vessel.
- venous valves While natural valves may function for an extended time, some may lose effectiveness, which can lead to physical manifestations and pathology. For example, venous valves are susceptible to becoming insufficient due to one or more of a variety of factors. Over time, the vessel wall may stretch, affecting the ability of the valve leaflets to close. Furthermore, the leaflets may become damaged, such as by formation of thrombus and scar tissue, which may also affect the ability of the valve leaflets to close. Once valves are damaged, venous valve insufficiency may be present, which can lead to discomfort and possibly ulcers in the legs and ankles.
- Minimally invasive techniques and instruments for placement of intraluminal medical devices have developed over recent years.
- a wide variety of treatment devices that utilize minimally invasive technology has been developed and includes stents, stent grafts, occlusion devices, infusion catheters and the like.
- Minimally invasive intravascular devices have especially become popular with the introduction of coronary stents to the U.S. market in the early 1990's.
- Coronary and peripheral stents have been proven to provide a superior means of maintaining vessel patency, and have become widely accepted in the medical community.
- the use of stents has been extended to treat aneurysms and to provide occlusion devices, among other uses.
- prosthetic valves have been developed that use a support frame such as a stent.
- a graft member is attached to the support frame and provides a valve function to the device.
- the graft member can be in the form of a leaflet that is attached to a stent and movable between first and second positions. In a first position, the valve is open and allows fluid flow to proceed through a vessel in a first direction, and in a second direction the valve is closed to prevent fluid flow in a second, opposite direction.
- An example of this type of prosthetic valve is described in commonly owned U.S. Pat. No.
- a tube that terminates in valve portions is attached to one or more support frames to form a valve.
- the valve portions open to permit fluid flow in a first direction in response to fluid pressure on one side of the portions, and close to prevent fluid flow in a second, opposite direction in response to fluid pressure on opposite sides of the portions.
- An example of this configuration is provided in U.S. Pat. No. 6,494,909 to Greenhalgh for AN ENDOVASCULAR VALVE, which is hereby incorporated by reference in its entirety.
- prosthetic valves One challenge in the development of prosthetic valves is the sizing of the valves.
- the body vessels in which the valves are placed exist in various sizes and configurations in any given patient population.
- prosthetic venous valves are designed for placement within a vein of a patient. These body vessels exist in a variety of sizes and have a high degree of elasticity. Accordingly, there is a need for medical devices, kits, and methods that are capable of being adapted to vessels of various sizes.
- the invention provides medical devices for implantation in a body vessel.
- a medical device comprises a main body having an outer surface and defining a passageway therethrough.
- a valve is disposed in the passageway and adapted to permit fluid flow through the passageway in a first direction and substantially prevent fluid flow through the passageway in a second, opposite direction.
- a vessel engaging member is disposed on the outer surface of the main body.
- a medical device comprises a main body having an outer surface and defining a passageway therethrough.
- a valve is disposed in the passageway and adapted to permit fluid flow through the passageway in a first direction and substantially prevent fluid flow through the passageway in a second, opposite direction.
- Means for engaging said body vessel are disposed on the outer surface of the main body.
- a medical device comprises a prosthetic valve having a stent and a tubular valve body disposed in a passageway defined by the stent.
- a vessel engaging member is disposed around the stent.
- a sheath can be disposed around the prosthetic valve and the elongate member.
- kits comprising a valve member comprising a main body defining a passageway and a valve disposed in the passageway.
- the valve is adapted to permit fluid flow through the passageway in a first direction and substantially prevent fluid flow through the passageway in a second, opposite direction.
- the kit also comprises a plurality of vessel engaging members.
- Each of the plurality of vessel engaging members comprises inner and outer edges and defines an opening adapted to receive the main body of the valve member.
- Each of the plurality of vessel engaging members has a dimension extending from the inner edge to the outer edge. Two of the plurality of vessel engaging members comprise different dimensions.
- a method of treatment according to the invention comprises providing a kit according to the invention; determining an inner diameter of a body vessel at a point of treatment; selecting a vessel engaging member having a suitable dimension; disposing the main body of a valve member in the opening of the vessel engaging member to form a medical device; and implanting the medical device at the point of treatment.
- FIG. 1 is a perspective view, partially broken away, of a medical device according to a first embodiment of the invention.
- FIG. 2 is a sectional view of the medical device of FIG. 1 within a body vessel with the valve in an open configuration.
- FIG. 3 is a sectional view of the medical device of FIG. 1 within a body vessel with the valve in a closed configuration.
- FIG. 4 is a perspective view, partially broken away, of a medical device according to a second embodiment of the invention.
- FIG. 5 is a sectional view of a medical device according to a third embodiment of the invention within a body vessel.
- FIG. 6 is a perspective view, partially broken away, of a medical device according to a fourth embodiment of the invention.
- FIG. 7 is a perspective view, partially broken away, of a medical device according to a fifth embodiment of the invention within a body vessel.
- FIG. 8 is a perspective view, partially broken away, of a medical device according to a sixth embodiment of the invention within a body vessel.
- FIG. 9 is a sectional view of a catheter according to an embodiment of the invention.
- FIG. 10 is a schematic illustrating a kit according to an embodiment of the invention.
- FIG. 11 is a flowchart of a method of treating a patient according to an embodiment of the invention.
- the invention provides medical devices for implantation in a body vessel, catheters, kits, and methods of treating patients that utilize medical devices according to the invention.
- FIGS. 1 through 3 illustrate a medical device 10 according to a first embodiment of the invention.
- the device 10 is an implantable medical device that comprises a main body 12 , a valve 14 , and a vessel engaging member 16 .
- the term “implantable” refers to an ability of a medical device to be positioned at a location within a body, such as within a body vessel. Furthermore, the terms “implantation” and “implanted” refer to the positioning of a medical device at a location within a body, such as within a body vessel.
- the main body 12 has proximal 18 and distal 20 ends and defines a passageway 22 extending between the ends 18 , 20 .
- the passageway 22 provides a path for fluid flow through main body 12 .
- An inner surface 24 of the main body 12 bounds the passageway 22 , and an outer surface 26 defines the exterior of the main body 12 .
- the main body 12 and the passageway 22 need not have any particular length, and the lengths can be optimized for a particular point of treatment.
- Any suitable structure defining a passageway can be utilized as the main body 12 .
- suitable structures include, without limitation, composite tubular structures, such as polymeric tubular structures, wire form structures, such as self-expandable stents, and balloon expandable stents, such as those cut from tubular members.
- Self-expandable and balloon expandable stents have a first, unexpanded configuration and a second, expanded configuration, which facilitates delivery and implantation by percutaneous techniques.
- the structure of the main body 12 can be formed from a variety of materials, and need only be biocompatible, or able to be made biocompatible.
- suitable materials include, without limitation, stainless steel, nickel titanium (NiTi) alloys, e.g., Nitinol, other shape memory and/or superelastic materials, polymers, and composite materials.
- NiTi nickel titanium
- a resorbable material can also be used for the main body 12 .
- the term “resorbable” refers to the ability of a material to be absorbed into a tissue and/or body fluid upon contact with the tissue and/or body fluid. A number of resorbable materials are known in the art, and any suitable resorbable material can be used.
- resorbable materials examples include resorbable homopolymers, copolymers, or blends of resorbable polymers.
- suitable resorbable materials include poly-alpha hydroxy acids such as polylactic acid, polylactide, polyglycolic acid (PGA), or polyglycolide; trimethylene carbonate; polycaprolactone; poly-beta hydroxy acids such as polyhydroxybutyrate or polyhydroxyvalerate; or other polymers such as polyphosphazines, polyorganophosphazines, polyanhydrides, polyesteramides, polyorthoesters, polyethylene oxide, polyester-ethers (e.g., polydioxanone) or polyamino acids (e.g., poly-L-glutamic acid or poly-L-lysine).
- modified polysaccharides such as cellulose, chitin, and dextran
- modified proteins such as fibrin and
- the main body 12 need not have any particular configuration, and the tubular configuration of the illustrated embodiment is exemplary in nature.
- the specific configuration and composition of the structure chosen for the main body 12 will depend on several factors, including the size of the body vessel in which the medical device 10 will be implanted, the quantity of fluid passed through the body vessel under normal physiological conditions, the quantity of fluid desired to be passed through the main body 12 following implantation in the body vessel, and the desired implantation technique. Those skilled in the art can determine an appropriate structure for the main body 12 based on all or some of these factors, and other factors.
- the structure chosen for the main body 12 should provide a structure to which the valve 14 can be attached.
- the valve 14 can be attached to the main body 12 in any suitable manner, such as by attachment elements, including sutures and adhesives, as well as friction, and other suitable fastening mechanisms and/or techniques.
- the main body 12 can include a portion 28 of the outer surface 26 that is impervious to fluid flow. When present, the impervious portion 28 can extend to the same axial length as the valve 14 . Also, the impervious portion 28 can extend axially beyond the valve 14 . This configuration encourages fluid to flow through the valve 14 and minimizes fluid flow that passes through the body vessel in which the device 10 is implanted without passing through the valve 14 .
- the impervious portion 28 can be a portion of the main body 12 itself, such as a portion of a tubular member, or it can be a separately attached member. Also, an impervious material can be used to form the valve 14 to achieve the desired result.
- a graft member 30 can be attached to main body 12 .
- the graft member 30 comprises the impervious portion 28 and extends from the proximal end 18 to the distal end 20 of the main body 12 .
- Any suitable graft material can be used to form the graft member 30 .
- the specific material chosen should provide the impervious portion 28 , if desired.
- suitable graft materials include polymers, such as polyurethane and polytetrafluoroethylene (PTFE), and natural materials, such as an extracellular matrix (ECM) material or other bioremodellable material.
- Small intestine submucosa is particularly well-suited for use as the graft member 30 at least due to its ability to remodel and become incorporated into host tissue.
- the graft member 30 can have any suitable configuration, including tubular and sheet configurations, and can be attached to any surface of the main body 12 , including either or both of the inner 24 and outer 26 surfaces. Similar to the valve 14 , the graft member 30 can be attached to the main body 12 in any suitable manner.
- the valve 14 is disposed in the passageway 22 and is adapted to permit fluid flow through the passageway 22 in a first direction 32 and substantially prevent fluid flow through the passageway 22 in a second, opposite direction 33 , i.e., retrograde flow.
- the valve 14 can be any suitable valve that is able to provide the desired ability to permit fluid flow in the first direction 32 and substantially prevent fluid flow in the second, opposite direction 33 .
- suitable valves include valves formed by attachment of one or more valve leaflets to a support frame, such as the prosthetic valves described in U.S. Pat. No. 6,508,833 to Pavcnik for a MULTIPLE-SIDED INTRALUMINAL MEDICAL DEVICE.
- suitable materials for the valve 14 include flexible materials, natural materials, synthetic materials, and combinations thereof.
- suitable natural materials include collagen, extracellular matrix (ECM) materials, such as submucosa, and other bioremodellable materials, such as bovine pericardium.
- ECM extracellular matrix
- SIS Small intestine submucosa
- Other examples of ECM materials that can be used for the graft member include stomach submucosa, liver basement membrane, urinary bladder submucosa, tissue mucosa, and dura mater. ECMs are particularly well-suited materials for use in the graft member, at least because of their abilities to remodel and become incorporated into adjacent tissues.
- Suitable synthetic materials include polymeric materials, such as polypropylene, polyurethane, and expanded polytetrafluoroethylene (ePTFE).
- the valve 14 can comprise a valve formed at one end 34 of a tubular body 36 .
- the valve 14 can be formed by forming valve portions 38 , 40 on one end 34 of the tubular body 36 .
- the valve portions 38 , 40 can be formed by attaching the tubular body 36 to the main body 12 in the illustrated configuration, or in any other suitable configuration that forms valve portions 38 , 40 .
- Any suitable attachment element and/or technique can be used to attach the tubular body 36 to the main body 12 and to form the valve portions 38 , 40 , such as sutures, adhesives, bonding, and the like. The specific attachment element and/or technique chosen will depend on several factors, including the materials and form of the valve 14 and the main body 12 .
- FIGS. 2 and 3 illustrate the medical device 10 according to the first embodiment positioned within a body vessel 50 .
- the valve 14 is in an open configuration. In this configuration, the valve 14 permits fluid flow through the passageway 22 in a first direction 32 .
- the valve 14 In the closed configuration, illustrated in FIG. 3 , the valve 14 substantially prevents fluid flow through the passageway 22 in a second, opposite direction 33 .
- the valve 14 can alternate between the open and closed configurations. The mechanism by which the valve 14 alternates between these configurations will depend on the type of valve used. When a tubular valve is used, such as the valve 14 illustrated in FIGS. 1 through 3 , the valve portions 38 , 40 can move in response to changes in direction of fluid flow and/or fluid pressure to accomplish the transition from the open configuration to the closed configuration, and vice versa.
- the vessel engaging member 16 provides a means for engaging a body vessel in which the medical device 10 is implanted.
- the vessel engaging member 16 defines an aperture 42 and has inner 44 and outer 46 edges.
- a dimension 48 such as a radial thickness, extends from the inner edge 44 to the outer edge 46 .
- the main body 12 is disposed in the aperture 42 .
- the vessel engaging member 16 substantially prevents fluid flow through the body vessel in which the device 10 is implanted apart from the fluid flow that moves through the valve 14 . Accordingly, the vessel engaging member 16 is dimensioned and configured to have a suitable fit with the main body 12 .
- the aperture 42 should be dimensioned and configured to provide an appropriate fit between the vessel engaging member 16 and the main body 12 .
- the fit should substantially prevent fluid flow through the interface between the member 16 and main body 12 , and should be sufficiently stable to prevent any significant movement of the main body 12 relative to the vessel engaging member 16 under physiological conditions following implantation of the device 10 in a body vessel.
- the aperture 42 can be dimensioned such that friction between the member 16 and the main body 12 is sufficient.
- a centrally-located aperture 42 of an appropriate dimension and configuration provides a suitable fit.
- the aperture 42 can have a diameter that is slightly smaller than an outer diameter of the main body 12 .
- the vessel engaging member 16 can be attached to the main body in any appropriate manner, such as by adhesives or other bonding mechanisms.
- the vessel engaging member 16 is also dimensioned and configured to have a suitable fit with the inner wall of a body vessel in which the device 10 is implanted.
- FIGS. 2 and 3 illustrate the medical device 10 of the first embodiment implanted within a body vessel 50 .
- the outer edge 46 of the vessel engaging member 16 can be dimensioned and configured to mimic the surface of the inner wall 52 of the vessel 50 .
- the devices of the present invention are particularly well suited for use as prosthetic venous valves. Accordingly, the vessel engaging member 16 can be dimensioned and configured to provide a suitable fit with the inner wall of an animal vein of interest. As illustrated in FIGS. 1 through 3 , a disc-shaped vessel engaging member 16 provides a suitable configuration for use in veins.
- the vessel engaging member 16 can have a diameter that is slightly larger than an inner diameter of the body vessel 50 at a particular point of treatment.
- Animal veins, including human veins, have elastic properties and are able to alter their shape by expansion or other mechanisms to accommodate an appropriately-sized article implanted within the vein.
- a vessel engaging member 16 with a diameter slightly larger than an inner diameter of a vein in which the device 10 is being implanted will remain at a point of treatment within the vein due to friction between the vessel engaging member 16 and the inner wall of the vein.
- This dimensioning of the vessel engaging member 16 may also enhance the fit between the member 16 and the main body 12 due to compression of the inner edge 44 on the main body 12 arising from force exerted on the member 16 by the body vessel.
- the specific diameter chosen for the vessel engaging member 16 will depend on several factors, including the extent to which the vein at a particular point of treatment can after its shape to accommodate the medical device 10 .
- any suitable material can be used to form the vessel engaging member 16 .
- the material chosen need only be biocompatible, or be able to be made biocompatible, and provide the desired properties described herein.
- the material chosen also should be substantially impervious to fluid flow through the material, unless it is desired to allow fluid flow through the body vessel independent of the valve 14 .
- the specific material chosen for the vessel engaging member 16 will depend on several factors, including the environment in which the device 10 will be placed, the nature of the fluid(s) to which the device 10 will be exposed, the nature of the body vessel in which the device 10 will be implanted, and the desired delivery technique for implanting the device 10 .
- suitable materials include synthetic materials, such as polymers, including polyurethane and polytetrafluoroethylene, and gels, and natural materials, such as ECM materials. Hydrogel materials are particularly well-suited for use in the vessel engaging member 16 .
- FIG. 4 illustrates a medical device 110 according to a second embodiment of the invention.
- the device 110 illustrated in FIG. 4 is similar to the device 10 illustrated in FIGS. 1 through 3 , except as detailed below.
- the device 110 of this embodiment includes a main body 112 , a valve 114 , and a vessel engaging member 116 .
- the main body 112 has a proximal 118 and a distal 120 end, and defines a passageway 122 extending between the ends 118 , 120 .
- An inner surface 124 of the main body 112 bounds the passageway 122 , and an outer surface 126 defines the exterior of the main body 112 .
- a graft member 130 is disposed on the main body 112 and defines an impervious portion 128 of the main body 112 .
- the valve 114 is disposed in the passageway 122 and is adapted to permit fluid flow through the passageway 122 in a first direction 132 , and substantially prevent fluid flow through the passageway 122 in a second, opposite direction (not illustrated in FIG. 4 ).
- the valve 114 is formed at one end 134 of a tubular body 136 , and includes valve portions 138 , 140 .
- the vessel engaging member 116 is disposed on the outer surface 126 of the main body 112 and defines an aperture 142 .
- the main body 112 is disposed in the aperture 142 .
- the vessel engaging member 116 has inner 144 and outer 146 edges and a radial dimension 148 that extends from the inner 144 to the outer 146 edges.
- the radial dimension 148 for any given pair of points on the inner 144 and outer 146 edges is different than the radial dimension for any different set of points on the edges 144 , 146 .
- the aperture 142 comprises an opening in the vessel engaging member that is continuous with the outer edge 146 of the vessel engaging member 116 . This positioning of the aperture 142 allows the main body 112 to be positioned near an inner wall of a vessel in which the device 110 is implanted, which may be desirable to avoid a diseased portion of a vessel, to bypass a blockage of the vessel, or for other reasons.
- FIG. 5 illustrates a sectional view of a medical device 210 according to a third embodiment of the invention within a body vessel 250 .
- the device 210 illustrated in FIG. 5 is similar to the device 10 illustrated in FIGS. 1 through 3 , except as detailed below.
- the device 210 of this embodiment includes a main body 212 , a valve 214 , and a vessel engaging member 216 .
- the main body 212 has a proximal 218 and a distal 220 end, and defines a passageway 222 extending between the ends 218 , 220 .
- An inner surface 224 of the main body 212 bounds the passageway 222 , and an outer surface 226 defines the exterior of the main body 212 .
- a graft member 230 is disposed on the main body 212 and defines an impervious portion 228 of the main body 212 .
- the valve 214 is disposed in the passageway 222 and is adapted to permit fluid flow through the passageway 222 in a first direction (not illustrated in FIG. 5 ), and substantially prevent fluid flow through the passageway 222 in a second, opposite direction 233 .
- the valve 214 is formed at an end 234 of a tubular body 236 , and includes valve portions 238 , 240 .
- the vessel engaging member 216 is disposed on the outer surface 226 of the main body 212 and defines an aperture 242 .
- the main body 212 is disposed in the aperture 242 .
- the vessel engaging member 216 has inner 244 and outer 246 edges and a radial dimension 248 that extends from the inner 244 to the outer 246 edges.
- the medical device 10 includes structural features 260 that pierce at least a portion of the wall of a body vessel 250 .
- the term “pierce” refers to a passing into a thickness of a wall of a body vessel.
- the thickness can be any partial or the complete thickness of the wall.
- the structural features 260 can comprise barbs, which are well known in the stent art.
- the structural features 260 can be positioned on the vessel engaging member 216 , as illustrated in FIG. 5 , or at any other position on the medical device 210 that enables their interaction with the body vessel 250 .
- any suitable number of structural features 260 can be included.
- structural features that frictionally engage, but do not pierce, the vessel wall are includes in the medical device.
- the outer surface of the vessel engaging member can define one or more raised bumps or indentations.
- FIG. 6 illustrates a medical device 310 according to a fourth embodiment of the invention within a body vessel 350 .
- the device 310 illustrated in FIG. 6 is similar to the device 10 illustrated in FIGS. 1 through 3 , except as detailed below.
- the device 310 of this embodiment includes a main body 312 , a valve 314 , and a vessel engaging member 316 .
- the main body 312 has a proximal 318 and a distal 320 end, and defines a passageway 322 extending between the ends 318 , 320 .
- An inner surface 324 of the main body 312 bounds the passageway 322 , and an outer surface 326 defines the exterior of the main body 312 .
- a graft member 330 is disposed on the main body 312 and defines an impervious portion 328 of the main body 312 .
- the valve 314 is disposed in the passageway 322 and is adapted to permit fluid flow through the passageway 322 in a first direction (not illustrated in FIG. 6 ), and substantially prevent fluid flow through the passageway 322 in a second, opposite direction 333 .
- the valve 314 is formed at an end 334 of a tubular body 336 , and includes valve portions 338 , 340 .
- the vessel engaging member 316 defines an opening 362 adapted to permit a controlled amount 363 of fluid flow through the body vessel in the second, opposite direction 333 .
- the controlled amount 363 of fluid flow is a portion of the fluid flow in the second, opposite direction 333 . It may be desirable to permit this controlled amount 363 of fluid flow in the second, opposite direction 333 for a variety of reasons. For example, it may reduce, minimize or eliminate pooling of fluid in and around the device 310 during periods of closure of the valve 314 .
- the vessel engaging member 316 can define a plurality of the openings 362 .
- the openings 362 can be arranged in any suitable pattern.
- An equidistant spacing between all openings 362 provides a suitable pattern and may maximize the efficiency of moving the controlled amount 363 of fluid flow through the vessel engaging member 316 .
- the dimensions, configuration, and number of the openings 362 can be optimized based upon the vessel in which the device 310 is implanted. The size and configuration selected will depend on several factors, including the vessel size, typical flow volumes and rates, and others.
- the opening 362 should be sized to allow a desired amount flow in the second, opposite direction to occur, while remaining sufficiently small to still allow the medical device 310 to act as a valve. Thus, the opening 362 can be sized so as not to allow a majority of retrograde flow to pass through the opening.
- the opening 362 can be sized to mimic the degree of retrograde flow—the leakiness—that flows through a natural valve located at or near the point of treatment.
- the dimensions of the opening 362 can be determined and optimized based upon the vessel in which the device 310 is to be placed.
- the total open area of the opening 362 can be less than about 50% of the cross-sectional area of the vessel, or less than about 25% of the total cross-sectional area of the vessel.
- a device is configured for placement in a vessel having a total cross-sectional area of about 50 mm 2 .
- the opening 362 has a total open area of about 10 mm 2 .
- the total open area of all openings 362 can be optimized as described above, but it is not necessary that the individual openings 362 have open areas of the same size.
- FIG. 7 illustrates a medical device 410 according to a fifth embodiment of the invention within a body vessel 450 .
- the device 410 illustrated in FIG. 7 is similar to the device 10 illustrated in FIGS. 1 through 3 , except as detailed below.
- the device 410 of this embodiment includes a main body 412 , a valve 414 , and a vessel engaging member 416 .
- the main body 412 has a proximal (not illustrated in FIG. 7 ) and a distal 420 end, and defines a passageway 422 extending between the ends 418 , 420 .
- An inner surface 424 of the main body 412 bounds the passageway 422 , and an outer surface 426 defines the exterior of the main body 412 .
- a graft member 430 is disposed on the main body 412 and defines an impervious portion 328 of the main body 312 .
- the valve 414 is disposed in the passageway 422 and is adapted to permit fluid flow through the passageway 422 in a first direction 432 , and substantially prevent fluid flow through the passageway 422 in a second, opposite direction (not illustrated in FIG. 7 ).
- the valve 414 is formed at one end 434 of a tubular body 436 , and includes valve portions 438 , 440 .
- FIG. 8 illustrates a medical device 510 according to a sixth embodiment of the invention within a body vessel 550 .
- the device 510 illustrated in FIG. 8 is similar to the device 410 illustrated in FIG. 7 , except as detailed below.
- the device 510 of this embodiment includes a main body 512 , a valve 514 , and a vessel engaging member 516 .
- the main body 512 has proximal and distal ends (not illustrated in FIG. 8 ), and defines a passageway 522 extending between the ends.
- An inner surface 524 of the main body 512 bounds the passageway 522 , and an outer surface 526 defines the exterior of the main body 512 .
- a graft member 530 is disposed on the main body 512 and defines an impervious portion 528 of the main body 512 .
- the valve 514 is disposed in the passageway 522 and is adapted to permit fluid flow through the passageway 522 in a first direction 532 , and substantially prevent fluid flow through the passageway 522 in a second, opposite direction (not illustrated in FIG. 8 ).
- the valve 514 is formed at an end 534 of a tubular body 536 , and includes valve portions 538 , 540 .
- the medical device 510 includes first 516 and second 580 vessel engaging members. Both vessel engaging member 516 , 580 are disposed on the outer surface 526 of the main body 512 .
- the first vessel engaging member 516 has first 570 and second 572 ends.
- the first end 572 defines a first opening 574 having a first inner diameter
- the second end 572 defines a second opening 576 having a second inner diameter.
- the first inner diameter is greater than the second inner diameter.
- the second end 572 is disposed on the outer surface 526 of the main body.
- This configuration of the first vessel engaging member 516 provides a manifold that collects fluid flowing through the body vessel 550 in the first direction 532 and directs the flow into the main body 512 and toward the valve 514 .
- the second vessel engaging member 580 has third 582 and fourth 584 ends.
- the third end defines a third opening 586 having a third inner diameter
- the fourth end 584 defines a fourth opening 588 having a fourth inner diameter.
- the third inner diameter is greater than the fourth inner diameter.
- the fourth end 584 is disposed on the outer surface 526 of the main body 512 .
- This configuration of the second vessel engaging member 580 provides a manifold that directs fluid exiting the valve 514 and main body 512 into the body vessel 550 .
- the first 516 and second 580 vessel engaging members create a void region 590 in the vessel 550 .
- the void region 590 is excluded from the flow pattern of fluid through the vessel 550 due to the configuration of the device 510 .
- the void region 590 can be used for anchoring the device 510 to the vessel 550 , such as by structural features discussed above, or by sutures or other securement means applied to the exterior of the vessel 550 .
- the void region 590 can be used to exclude a portion of the body vessel 550 from fluid flow, such as a diseased portion of the vessel 550 .
- FIG. 9 illustrates a delivery device 600 according to an embodiment of the invention.
- the delivery device 600 comprises a suitable elongate member 602 known to those skilled in the art.
- the elongate member 602 has a distal tip 604 and defines an external surface 606 .
- a medical device 610 according to the present invention is disposed on the distal tip 604 by passing the tip 604 through the passageway 622 of the main body 612 of the device 610 .
- the delivery device 600 can include a sheath 608 disposed over the elongate member 602 .
- the sheath 608 is a hollow member that defines a lumen 609 that receives the elongate member 602 .
- the elongate member 602 can define a guidewire lumen 607 that facilitates navigation of the member 602 through a body vessel by accommodating a previously placed guidewire.
- the guidewire lumen 607 can extend along the entire length of the elongate member 602 , or only along a portion of the length, as in a rapid exchange arrangement known in the art.
- a catheter according to this aspect of the invention can facilitate placement of multiple prosthetic valves in a single vessel by allowing for rapid exchange of one catheter carrying a medical device according to the invention for another without removal of a previously placed guidewire. This may be particularly desirable in prosthetic venous valve embodiments because it may be desirable to place two or more such devices in a single vessel during a single treatment.
- FIG. 10 illustrates a kit 700 according to the invention.
- the kit 700 comprises a valve member 702 and a plurality of vessel engaging members 704 .
- the valve member 702 comprises a main body 706 defining a passageway 708 and a valve 710 disposed in the passageway 708 and can be any suitable main body and valve combination according to the invention, including those detailed in the context of exemplary embodiments above.
- the valve 710 is adapted to permit fluid flow through the passageway 708 in a first direction, and substantially prevent fluid flow through the passageway 708 in a second, opposite direction.
- the kit 700 can include a plurality of valve members 702 .
- the kit 700 can further include a catheter to facilitate implantation of the medical device.
- Each vessel engaging member 704 has inner 712 and outer 714 edges, and defines an aperture 716 adapted to receive a valve member 702 . Also, each vessel engaging member defines a radial dimension extending between its inner 712 and outer 714 edges.
- Two of the plurality of vessel engaging members 704 have different radial dimensions extending between their respective inner 712 and outer 714 edges.
- the kit illustrated in FIG. 10 includes three vessel engaging members 704 having three different dimensions 718 , 720 , and 722 .
- the vessel engaging members 704 of the kit 700 illustrated in FIG. 10 all have apertures 716 of the same diameter 724 . If a plurality of valve members is included in a kit, and two valve members have main bodies of different outer diameters, the diameters of the apertures 716 could be varied in a manner similar to that of the radial dimensions 718 , 720 , 722 .
- a medical device in accordance with the present invention can be made by disposing a valve member 702 in the aperture 716 of one of the plurality of vessel engaging members 704 .
- the kit 700 allows a user to assemble a medical device according to the present invention with a dimension suitable for an application of interest.
- a clinician can assemble a medical device having a vessel engaging member 704 with a dimension appropriate for implantation of the device in a vein of a patient.
- the dimension can be determined by determining the inner diameter of the vein at a point of treatment.
- FIG. 11 provides a flow chart illustrating one method 800 according to the invention.
- step 802 comprises providing a kit according to the invention.
- step 804 comprises determining an inner diameter of a body vessel at a point of treatment. This step can be accomplished by any appropriate vessel sizing technique known in the art.
- step 806 comprises selecting a suitable vessel engaging member from the plurality of vessel engaging members in the kit. The selected vessel engaging member must have a dimension that is appropriate for the treatment based upon the inner diameter determined in step 804 .
- the selection of an appropriate vessel engaging member can take into account the ability of the vessel to after its shape to accommodate an implanted article, as explained above.
- Another step 808 comprises disposing the main body of a selected valve member from the kit in the aperture of the selected vessel engaging member to form a medical device according to the invention.
- Another step 810 comprises implanting the assembled medical device at the point of treatment in the body vessel.
- a step 812 of percutaneously delivering the medical device to the point of treatment can also be included. Step 812 can be accomplished by appropriate percutaneous techniques known in the art.
Abstract
Medical devices for implantation in a body vessel are provided. Each medical device comprises a main body, a valve, and a vessel engaging member. The vessel engaging member is disposed on an outer surface of the main body. Kits including a plurality of vessel engaging members for use with one or more valve members are also provided. The vessel engaging members have varying radial dimensions, allowing assembly of medical devices having varying radial dimensions. Methods of treating a patient using medical devices according to the invention are also provided.
Description
- This application is a continuation of U.S. patent application Ser. No. 10/857,403, filed on May 28, 2004, which claims priority to U.S. Provisional Application Ser. No. 60/473,911, filed on May 28, 2003. Each of these applications is hereby incorporated into this disclosure in its entirety.
- The present invention relates to medical devices. More particularly, the invention relates to medical devices for implantation in a body vessel.
- Many vessels in animals transport fluids from one bodily location to another. Frequently, fluid flows in a unidirectional manner along the length of the vessel. Varying fluid pressures over time, however, can introduce a reverse flow direction in the vessel. In some vessels, such as mammalian veins, natural valves are positioned along the length of the vessel and act as one-way check valves that open to permit the flow of fluid in the desired direction, and quickly close upon a change in pressure, such as a transition from systole to diastole, to prevent fluid flow in a reverse direction, i.e., retrograde flow.
- While natural valves may function for an extended time, some may lose effectiveness, which can lead to physical manifestations and pathology. For example, venous valves are susceptible to becoming insufficient due to one or more of a variety of factors. Over time, the vessel wall may stretch, affecting the ability of the valve leaflets to close. Furthermore, the leaflets may become damaged, such as by formation of thrombus and scar tissue, which may also affect the ability of the valve leaflets to close. Once valves are damaged, venous valve insufficiency may be present, which can lead to discomfort and possibly ulcers in the legs and ankles.
- Current treatments for venous valve insufficiency include surgical techniques in which valves are bypassed or replaced with autologous sections of veins with competent valves. These techniques are generally undesirable because they represent a relatively invasive approach to treating valve insufficiency.
- Minimally invasive techniques and instruments for placement of intraluminal medical devices have developed over recent years. A wide variety of treatment devices that utilize minimally invasive technology has been developed and includes stents, stent grafts, occlusion devices, infusion catheters and the like. Minimally invasive intravascular devices have especially become popular with the introduction of coronary stents to the U.S. market in the early 1990's. Coronary and peripheral stents have been proven to provide a superior means of maintaining vessel patency, and have become widely accepted in the medical community. Furthermore, the use of stents has been extended to treat aneurysms and to provide occlusion devices, among other uses.
- Recently, prosthetic valves have been developed that use a support frame such as a stent. Frequently, a graft member is attached to the support frame and provides a valve function to the device. For example, the graft member can be in the form of a leaflet that is attached to a stent and movable between first and second positions. In a first position, the valve is open and allows fluid flow to proceed through a vessel in a first direction, and in a second direction the valve is closed to prevent fluid flow in a second, opposite direction. An example of this type of prosthetic valve is described in commonly owned U.S. Pat. No. 6,508,833, to Pavcnik for a MULTIPLE-SIDED INTRALUMINAL MEDICAL DEVICE, which is hereby incorporated by reference in its entirety. In other examples of prosthetic valves, a tube that terminates in valve portions is attached to one or more support frames to form a valve. The valve portions open to permit fluid flow in a first direction in response to fluid pressure on one side of the portions, and close to prevent fluid flow in a second, opposite direction in response to fluid pressure on opposite sides of the portions. An example of this configuration is provided in U.S. Pat. No. 6,494,909 to Greenhalgh for AN ENDOVASCULAR VALVE, which is hereby incorporated by reference in its entirety.
- One challenge in the development of prosthetic valves is the sizing of the valves. The body vessels in which the valves are placed exist in various sizes and configurations in any given patient population. For example, prosthetic venous valves are designed for placement within a vein of a patient. These body vessels exist in a variety of sizes and have a high degree of elasticity. Accordingly, there is a need for medical devices, kits, and methods that are capable of being adapted to vessels of various sizes.
- The invention provides medical devices for implantation in a body vessel.
- In one exemplary embodiment, a medical device according to the invention comprises a main body having an outer surface and defining a passageway therethrough. A valve is disposed in the passageway and adapted to permit fluid flow through the passageway in a first direction and substantially prevent fluid flow through the passageway in a second, opposite direction. A vessel engaging member is disposed on the outer surface of the main body.
- In one exemplary embodiment, a medical device according to the invention comprises a main body having an outer surface and defining a passageway therethrough. A valve is disposed in the passageway and adapted to permit fluid flow through the passageway in a first direction and substantially prevent fluid flow through the passageway in a second, opposite direction. Means for engaging said body vessel are disposed on the outer surface of the main body.
- In one exemplary embodiment, a medical device according to the invention comprises a prosthetic valve having a stent and a tubular valve body disposed in a passageway defined by the stent. A vessel engaging member is disposed around the stent.
- The invention also provides delivery devices. In one embodiment, a delivery device according to the invention comprises an elongate member comprising a distal end and a prosthetic valve according to the invention disposed on the distal end. A sheath can be disposed around the prosthetic valve and the elongate member.
- The invention also provides kits. In one embodiment, a kit according to the invention comprises a valve member comprising a main body defining a passageway and a valve disposed in the passageway. The valve is adapted to permit fluid flow through the passageway in a first direction and substantially prevent fluid flow through the passageway in a second, opposite direction. The kit also comprises a plurality of vessel engaging members. Each of the plurality of vessel engaging members comprises inner and outer edges and defines an opening adapted to receive the main body of the valve member. Each of the plurality of vessel engaging members has a dimension extending from the inner edge to the outer edge. Two of the plurality of vessel engaging members comprise different dimensions.
- The invention also provides methods of treating a patient. In one embodiment, a method of treatment according to the invention comprises providing a kit according to the invention; determining an inner diameter of a body vessel at a point of treatment; selecting a vessel engaging member having a suitable dimension; disposing the main body of a valve member in the opening of the vessel engaging member to form a medical device; and implanting the medical device at the point of treatment.
- The invention includes other embodiments within the scope of the claims, and variations of all embodiments, and is limited only by the claims made by the applicants. Additional understanding of the invention can be obtained by referencing the detailed description of exemplary embodiments of the invention, below, and the appended drawings.
-
FIG. 1 is a perspective view, partially broken away, of a medical device according to a first embodiment of the invention. -
FIG. 2 is a sectional view of the medical device ofFIG. 1 within a body vessel with the valve in an open configuration. -
FIG. 3 is a sectional view of the medical device ofFIG. 1 within a body vessel with the valve in a closed configuration. -
FIG. 4 is a perspective view, partially broken away, of a medical device according to a second embodiment of the invention. -
FIG. 5 is a sectional view of a medical device according to a third embodiment of the invention within a body vessel. -
FIG. 6 is a perspective view, partially broken away, of a medical device according to a fourth embodiment of the invention. -
FIG. 7 is a perspective view, partially broken away, of a medical device according to a fifth embodiment of the invention within a body vessel. -
FIG. 8 is a perspective view, partially broken away, of a medical device according to a sixth embodiment of the invention within a body vessel. -
FIG. 9 is a sectional view of a catheter according to an embodiment of the invention. -
FIG. 10 is a schematic illustrating a kit according to an embodiment of the invention. -
FIG. 11 is a flowchart of a method of treating a patient according to an embodiment of the invention. - The following detailed description and appended drawings describe and illustrate various exemplary embodiments of the invention. The description and drawings serve to enable one skilled in the art to make and use the invention, and are not intended to limit the scope of the invention, or its protection, in any manner.
- The invention provides medical devices for implantation in a body vessel, catheters, kits, and methods of treating patients that utilize medical devices according to the invention.
-
FIGS. 1 through 3 illustrate amedical device 10 according to a first embodiment of the invention. Thedevice 10 is an implantable medical device that comprises amain body 12, avalve 14, and avessel engaging member 16. - As used herein, the term “implantable” refers to an ability of a medical device to be positioned at a location within a body, such as within a body vessel. Furthermore, the terms “implantation” and “implanted” refer to the positioning of a medical device at a location within a body, such as within a body vessel.
- The
main body 12 has proximal 18 and distal 20 ends and defines apassageway 22 extending between theends passageway 22 provides a path for fluid flow throughmain body 12. Aninner surface 24 of themain body 12 bounds thepassageway 22, and anouter surface 26 defines the exterior of themain body 12. Themain body 12 and thepassageway 22 need not have any particular length, and the lengths can be optimized for a particular point of treatment. - Any suitable structure defining a passageway can be utilized as the
main body 12. Examples of suitable structures include, without limitation, composite tubular structures, such as polymeric tubular structures, wire form structures, such as self-expandable stents, and balloon expandable stents, such as those cut from tubular members. Self-expandable and balloon expandable stents have a first, unexpanded configuration and a second, expanded configuration, which facilitates delivery and implantation by percutaneous techniques. - The structure of the
main body 12 can be formed from a variety of materials, and need only be biocompatible, or able to be made biocompatible. Examples of suitable materials include, without limitation, stainless steel, nickel titanium (NiTi) alloys, e.g., Nitinol, other shape memory and/or superelastic materials, polymers, and composite materials. A resorbable material can also be used for themain body 12. As used herein, the term “resorbable” refers to the ability of a material to be absorbed into a tissue and/or body fluid upon contact with the tissue and/or body fluid. A number of resorbable materials are known in the art, and any suitable resorbable material can be used. Examples of suitable types of resorbable materials include resorbable homopolymers, copolymers, or blends of resorbable polymers. Specific examples of suitable resorbable materials include poly-alpha hydroxy acids such as polylactic acid, polylactide, polyglycolic acid (PGA), or polyglycolide; trimethylene carbonate; polycaprolactone; poly-beta hydroxy acids such as polyhydroxybutyrate or polyhydroxyvalerate; or other polymers such as polyphosphazines, polyorganophosphazines, polyanhydrides, polyesteramides, polyorthoesters, polyethylene oxide, polyester-ethers (e.g., polydioxanone) or polyamino acids (e.g., poly-L-glutamic acid or poly-L-lysine). There are also a number of naturally derived resorbable polymers that may be suitable, including modified polysaccharides, such as cellulose, chitin, and dextran, and modified proteins, such as fibrin and casein. - The
main body 12 need not have any particular configuration, and the tubular configuration of the illustrated embodiment is exemplary in nature. The specific configuration and composition of the structure chosen for themain body 12 will depend on several factors, including the size of the body vessel in which themedical device 10 will be implanted, the quantity of fluid passed through the body vessel under normal physiological conditions, the quantity of fluid desired to be passed through themain body 12 following implantation in the body vessel, and the desired implantation technique. Those skilled in the art can determine an appropriate structure for themain body 12 based on all or some of these factors, and other factors. - The structure chosen for the
main body 12 should provide a structure to which thevalve 14 can be attached. Thevalve 14 can be attached to themain body 12 in any suitable manner, such as by attachment elements, including sutures and adhesives, as well as friction, and other suitable fastening mechanisms and/or techniques. Themain body 12 can include aportion 28 of theouter surface 26 that is impervious to fluid flow. When present, theimpervious portion 28 can extend to the same axial length as thevalve 14. Also, theimpervious portion 28 can extend axially beyond thevalve 14. This configuration encourages fluid to flow through thevalve 14 and minimizes fluid flow that passes through the body vessel in which thedevice 10 is implanted without passing through thevalve 14. Theimpervious portion 28 can be a portion of themain body 12 itself, such as a portion of a tubular member, or it can be a separately attached member. Also, an impervious material can be used to form thevalve 14 to achieve the desired result. - As best illustrated in
FIG. 1 , agraft member 30 can be attached tomain body 12. In this embodiment, thegraft member 30 comprises theimpervious portion 28 and extends from theproximal end 18 to thedistal end 20 of themain body 12. Any suitable graft material can be used to form thegraft member 30. The specific material chosen should provide theimpervious portion 28, if desired. Examples of suitable graft materials include polymers, such as polyurethane and polytetrafluoroethylene (PTFE), and natural materials, such as an extracellular matrix (ECM) material or other bioremodellable material. Small intestine submucosa (SIS) is particularly well-suited for use as thegraft member 30 at least due to its ability to remodel and become incorporated into host tissue. Also, thegraft member 30 can have any suitable configuration, including tubular and sheet configurations, and can be attached to any surface of themain body 12, including either or both of the inner 24 and outer 26 surfaces. Similar to thevalve 14, thegraft member 30 can be attached to themain body 12 in any suitable manner. - The
valve 14 is disposed in thepassageway 22 and is adapted to permit fluid flow through thepassageway 22 in afirst direction 32 and substantially prevent fluid flow through thepassageway 22 in a second,opposite direction 33, i.e., retrograde flow. Thevalve 14 can be any suitable valve that is able to provide the desired ability to permit fluid flow in thefirst direction 32 and substantially prevent fluid flow in the second,opposite direction 33. Examples of suitable valves include valves formed by attachment of one or more valve leaflets to a support frame, such as the prosthetic valves described in U.S. Pat. No. 6,508,833 to Pavcnik for a MULTIPLE-SIDED INTRALUMINAL MEDICAL DEVICE. - Examples of suitable materials for the
valve 14 include flexible materials, natural materials, synthetic materials, and combinations thereof. Examples of suitable natural materials include collagen, extracellular matrix (ECM) materials, such as submucosa, and other bioremodellable materials, such as bovine pericardium. Small intestine submucosa (SIS) is particularly well-suited for use as thegraft members - Tubular valves are also suitable for use in medical devices according to the invention. As best illustrated in
FIG. 1 , thevalve 14 can comprise a valve formed at oneend 34 of atubular body 36. Thevalve 14 can be formed by formingvalve portions end 34 of thetubular body 36. Thevalve portions tubular body 36 to themain body 12 in the illustrated configuration, or in any other suitable configuration that formsvalve portions tubular body 36 to themain body 12 and to form thevalve portions valve 14 and themain body 12. -
FIGS. 2 and 3 illustrate themedical device 10 according to the first embodiment positioned within abody vessel 50. InFIG. 2 , thevalve 14 is in an open configuration. In this configuration, thevalve 14 permits fluid flow through thepassageway 22 in afirst direction 32. In the closed configuration, illustrated inFIG. 3 , thevalve 14 substantially prevents fluid flow through thepassageway 22 in a second,opposite direction 33. Thevalve 14 can alternate between the open and closed configurations. The mechanism by which thevalve 14 alternates between these configurations will depend on the type of valve used. When a tubular valve is used, such as thevalve 14 illustrated inFIGS. 1 through 3 , thevalve portions - The
vessel engaging member 16 provides a means for engaging a body vessel in which themedical device 10 is implanted. Thevessel engaging member 16 defines anaperture 42 and has inner 44 and outer 46 edges. Adimension 48, such as a radial thickness, extends from the inner edge 44 to theouter edge 46. Themain body 12 is disposed in theaperture 42. Thevessel engaging member 16 substantially prevents fluid flow through the body vessel in which thedevice 10 is implanted apart from the fluid flow that moves through thevalve 14. Accordingly, thevessel engaging member 16 is dimensioned and configured to have a suitable fit with themain body 12. Specifically, theaperture 42 should be dimensioned and configured to provide an appropriate fit between thevessel engaging member 16 and themain body 12. The fit should substantially prevent fluid flow through the interface between themember 16 andmain body 12, and should be sufficiently stable to prevent any significant movement of themain body 12 relative to thevessel engaging member 16 under physiological conditions following implantation of thedevice 10 in a body vessel. To achieve an appropriate fit, theaperture 42 can be dimensioned such that friction between themember 16 and themain body 12 is sufficient. As illustrated inFIG. 1 , a centrally-locatedaperture 42 of an appropriate dimension and configuration provides a suitable fit. To ensure an effective fit, theaperture 42 can have a diameter that is slightly smaller than an outer diameter of themain body 12. Also, thevessel engaging member 16 can be attached to the main body in any appropriate manner, such as by adhesives or other bonding mechanisms. - The
vessel engaging member 16 is also dimensioned and configured to have a suitable fit with the inner wall of a body vessel in which thedevice 10 is implanted.FIGS. 2 and 3 illustrate themedical device 10 of the first embodiment implanted within abody vessel 50. Theouter edge 46 of thevessel engaging member 16 can be dimensioned and configured to mimic the surface of theinner wall 52 of thevessel 50. The devices of the present invention are particularly well suited for use as prosthetic venous valves. Accordingly, thevessel engaging member 16 can be dimensioned and configured to provide a suitable fit with the inner wall of an animal vein of interest. As illustrated inFIGS. 1 through 3 , a disc-shapedvessel engaging member 16 provides a suitable configuration for use in veins. - To ensure a suitable fit between the
vessel engaging member 16 and thebody vessel 50, thevessel engaging member 16 can have a diameter that is slightly larger than an inner diameter of thebody vessel 50 at a particular point of treatment. Animal veins, including human veins, have elastic properties and are able to alter their shape by expansion or other mechanisms to accommodate an appropriately-sized article implanted within the vein. Avessel engaging member 16 with a diameter slightly larger than an inner diameter of a vein in which thedevice 10 is being implanted will remain at a point of treatment within the vein due to friction between thevessel engaging member 16 and the inner wall of the vein. This dimensioning of thevessel engaging member 16 may also enhance the fit between themember 16 and themain body 12 due to compression of the inner edge 44 on themain body 12 arising from force exerted on themember 16 by the body vessel. The specific diameter chosen for thevessel engaging member 16 will depend on several factors, including the extent to which the vein at a particular point of treatment can after its shape to accommodate themedical device 10. - Any suitable material can be used to form the
vessel engaging member 16. The material chosen need only be biocompatible, or be able to be made biocompatible, and provide the desired properties described herein. The material chosen also should be substantially impervious to fluid flow through the material, unless it is desired to allow fluid flow through the body vessel independent of thevalve 14. The specific material chosen for thevessel engaging member 16 will depend on several factors, including the environment in which thedevice 10 will be placed, the nature of the fluid(s) to which thedevice 10 will be exposed, the nature of the body vessel in which thedevice 10 will be implanted, and the desired delivery technique for implanting thedevice 10. Examples of suitable materials include synthetic materials, such as polymers, including polyurethane and polytetrafluoroethylene, and gels, and natural materials, such as ECM materials. Hydrogel materials are particularly well-suited for use in thevessel engaging member 16. -
FIG. 4 illustrates a medical device 110 according to a second embodiment of the invention. The device 110 illustrated inFIG. 4 is similar to thedevice 10 illustrated inFIGS. 1 through 3 , except as detailed below. Thus, the device 110 of this embodiment includes amain body 112, avalve 114, and avessel engaging member 116. Themain body 112 has a proximal 118 and a distal 120 end, and defines apassageway 122 extending between theends inner surface 124 of themain body 112 bounds thepassageway 122, and an outer surface 126 defines the exterior of themain body 112. Agraft member 130 is disposed on themain body 112 and defines animpervious portion 128 of themain body 112. - The
valve 114 is disposed in thepassageway 122 and is adapted to permit fluid flow through thepassageway 122 in afirst direction 132, and substantially prevent fluid flow through thepassageway 122 in a second, opposite direction (not illustrated inFIG. 4 ). Thevalve 114 is formed at oneend 134 of atubular body 136, and includesvalve portions - The
vessel engaging member 116 is disposed on the outer surface 126 of themain body 112 and defines anaperture 142. Themain body 112 is disposed in theaperture 142. Thevessel engaging member 116 has inner 144 and outer 146 edges and aradial dimension 148 that extends from the inner 144 to the outer 146 edges. In this embodiment, theradial dimension 148 for any given pair of points on the inner 144 and outer 146 edges is different than the radial dimension for any different set of points on theedges - In this embodiment, the
aperture 142 comprises an opening in the vessel engaging member that is continuous with theouter edge 146 of thevessel engaging member 116. This positioning of theaperture 142 allows themain body 112 to be positioned near an inner wall of a vessel in which the device 110 is implanted, which may be desirable to avoid a diseased portion of a vessel, to bypass a blockage of the vessel, or for other reasons. -
FIG. 5 illustrates a sectional view of amedical device 210 according to a third embodiment of the invention within abody vessel 250. Thedevice 210 illustrated inFIG. 5 is similar to thedevice 10 illustrated inFIGS. 1 through 3 , except as detailed below. Thus, thedevice 210 of this embodiment includes amain body 212, avalve 214, and avessel engaging member 216. Themain body 212 has a proximal 218 and a distal 220 end, and defines apassageway 222 extending between theends inner surface 224 of themain body 212 bounds thepassageway 222, and anouter surface 226 defines the exterior of themain body 212. Agraft member 230 is disposed on themain body 212 and defines animpervious portion 228 of themain body 212. - The
valve 214 is disposed in thepassageway 222 and is adapted to permit fluid flow through thepassageway 222 in a first direction (not illustrated inFIG. 5 ), and substantially prevent fluid flow through thepassageway 222 in a second,opposite direction 233. Thevalve 214 is formed at anend 234 of atubular body 236, and includesvalve portions - The
vessel engaging member 216 is disposed on theouter surface 226 of themain body 212 and defines anaperture 242. Themain body 212 is disposed in theaperture 242. Thevessel engaging member 216 has inner 244 and outer 246 edges and aradial dimension 248 that extends from the inner 244 to the outer 246 edges. - In this embodiment, the
medical device 10 includesstructural features 260 that pierce at least a portion of the wall of abody vessel 250. As used herein, the term “pierce” refers to a passing into a thickness of a wall of a body vessel. The thickness can be any partial or the complete thickness of the wall. Thestructural features 260 can comprise barbs, which are well known in the stent art. Also, thestructural features 260 can be positioned on thevessel engaging member 216, as illustrated inFIG. 5 , or at any other position on themedical device 210 that enables their interaction with thebody vessel 250. Furthermore, any suitable number ofstructural features 260 can be included. In other embodiments, structural features that frictionally engage, but do not pierce, the vessel wall are includes in the medical device. For example, the outer surface of the vessel engaging member can define one or more raised bumps or indentations. -
FIG. 6 illustrates amedical device 310 according to a fourth embodiment of the invention within a body vessel 350. Thedevice 310 illustrated inFIG. 6 is similar to thedevice 10 illustrated inFIGS. 1 through 3 , except as detailed below. Thus, thedevice 310 of this embodiment includes amain body 312, avalve 314, and avessel engaging member 316. Themain body 312 has a proximal 318 and a distal 320 end, and defines apassageway 322 extending between theends inner surface 324 of themain body 312 bounds thepassageway 322, and anouter surface 326 defines the exterior of themain body 312. Agraft member 330 is disposed on themain body 312 and defines animpervious portion 328 of themain body 312. - The
valve 314 is disposed in thepassageway 322 and is adapted to permit fluid flow through thepassageway 322 in a first direction (not illustrated inFIG. 6 ), and substantially prevent fluid flow through thepassageway 322 in a second,opposite direction 333. Thevalve 314 is formed at anend 334 of atubular body 336, and includesvalve portions - The
vessel engaging member 316 is disposed on theouter surface 326 of themain body 312 and defines anaperture 342. Themain body 312 is disposed in theaperture 342. Thevessel engaging member 316 has inner 344 and outer 346 edges and aradial dimension 348 that extends from the inner 344 to the outer 346 edges. - In this embodiment, the
vessel engaging member 316 defines anopening 362 adapted to permit a controlledamount 363 of fluid flow through the body vessel in the second,opposite direction 333. The controlledamount 363 of fluid flow is a portion of the fluid flow in the second,opposite direction 333. It may be desirable to permit this controlledamount 363 of fluid flow in the second,opposite direction 333 for a variety of reasons. For example, it may reduce, minimize or eliminate pooling of fluid in and around thedevice 310 during periods of closure of thevalve 314. - As illustrated in
FIG. 6 , thevessel engaging member 316 can define a plurality of theopenings 362. When a plurality ofopenings 362 is utilized, theopenings 362 can be arranged in any suitable pattern. An equidistant spacing between allopenings 362 provides a suitable pattern and may maximize the efficiency of moving the controlledamount 363 of fluid flow through thevessel engaging member 316. - The dimensions, configuration, and number of the
openings 362 can be optimized based upon the vessel in which thedevice 310 is implanted. The size and configuration selected will depend on several factors, including the vessel size, typical flow volumes and rates, and others. Theopening 362 should be sized to allow a desired amount flow in the second, opposite direction to occur, while remaining sufficiently small to still allow themedical device 310 to act as a valve. Thus, theopening 362 can be sized so as not to allow a majority of retrograde flow to pass through the opening. - The
opening 362 can be sized to mimic the degree of retrograde flow—the leakiness—that flows through a natural valve located at or near the point of treatment. In these embodiments, the dimensions of theopening 362 can be determined and optimized based upon the vessel in which thedevice 310 is to be placed. For example, in prosthetic venous valve embodiments, the total open area of theopening 362 can be less than about 50% of the cross-sectional area of the vessel, or less than about 25% of the total cross-sectional area of the vessel. In one example, a device is configured for placement in a vessel having a total cross-sectional area of about 50 mm2. In this example, theopening 362 has a total open area of about 10 mm2. - In devices including
multiple openings 362 that permit a controlledamount 363 of fluid flow in the second,opposite direction 333 to flow through the vessel in which thedevice 310 is implanted, the total open area of allopenings 362 can be optimized as described above, but it is not necessary that theindividual openings 362 have open areas of the same size. -
FIG. 7 illustrates amedical device 410 according to a fifth embodiment of the invention within abody vessel 450. Thedevice 410 illustrated inFIG. 7 is similar to thedevice 10 illustrated inFIGS. 1 through 3 , except as detailed below. Thus, thedevice 410 of this embodiment includes amain body 412, avalve 414, and avessel engaging member 416. Themain body 412 has a proximal (not illustrated inFIG. 7 ) and a distal 420 end, and defines apassageway 422 extending between theends 418, 420. Aninner surface 424 of themain body 412 bounds thepassageway 422, and an outer surface 426 defines the exterior of themain body 412. Agraft member 430 is disposed on themain body 412 and defines animpervious portion 328 of themain body 312. - The
valve 414 is disposed in thepassageway 422 and is adapted to permit fluid flow through thepassageway 422 in afirst direction 432, and substantially prevent fluid flow through thepassageway 422 in a second, opposite direction (not illustrated inFIG. 7 ). Thevalve 414 is formed at oneend 434 of atubular body 436, and includesvalve portions 438, 440. - The
vessel engaging member 416 is disposed on the outer surface 426 of themain body 412. Thevessel engaging member 416 has first 470 and second 472 ends. Thefirst end 472 defines afirst opening 474 having a first inner diameter, and thesecond end 472 defines asecond opening 476 having a second inner diameter. The first inner diameter is greater than the second inner diameter. Thesecond end 472 is disposed on the outer surface 426 of the main body. This configuration of thevessel engaging member 416 provides a manifold that collects fluid flowing through thebody vessel 450 in thefirst direction 432 and directs the flow into themain body 412 and toward thevalve 414. A graft material, such as SIS and other bioremodellable materials, is particularly well-suited for use as thevessel engaging member 416 in medical devices according to this embodiment of the invention. -
FIG. 8 illustrates amedical device 510 according to a sixth embodiment of the invention within abody vessel 550. Thedevice 510 illustrated inFIG. 8 is similar to thedevice 410 illustrated inFIG. 7 , except as detailed below. Thus, thedevice 510 of this embodiment includes amain body 512, avalve 514, and avessel engaging member 516. Themain body 512 has proximal and distal ends (not illustrated inFIG. 8 ), and defines apassageway 522 extending between the ends. Aninner surface 524 of themain body 512 bounds thepassageway 522, and anouter surface 526 defines the exterior of themain body 512. Agraft member 530 is disposed on themain body 512 and defines animpervious portion 528 of themain body 512. - The
valve 514 is disposed in thepassageway 522 and is adapted to permit fluid flow through thepassageway 522 in afirst direction 532, and substantially prevent fluid flow through thepassageway 522 in a second, opposite direction (not illustrated inFIG. 8 ). Thevalve 514 is formed at anend 534 of atubular body 536, and includesvalve portions 538, 540. - In this embodiment, the
medical device 510 includes first 516 and second 580 vessel engaging members. Bothvessel engaging member outer surface 526 of themain body 512. The firstvessel engaging member 516 has first 570 and second 572 ends. Thefirst end 572 defines afirst opening 574 having a first inner diameter, and thesecond end 572 defines asecond opening 576 having a second inner diameter. The first inner diameter is greater than the second inner diameter. Thesecond end 572 is disposed on theouter surface 526 of the main body. This configuration of the firstvessel engaging member 516 provides a manifold that collects fluid flowing through thebody vessel 550 in thefirst direction 532 and directs the flow into themain body 512 and toward thevalve 514. - The second
vessel engaging member 580 has third 582 and fourth 584 ends. The third end defines athird opening 586 having a third inner diameter, and thefourth end 584 defines a fourth opening 588 having a fourth inner diameter. The third inner diameter is greater than the fourth inner diameter. Thefourth end 584 is disposed on theouter surface 526 of themain body 512. This configuration of the secondvessel engaging member 580 provides a manifold that directs fluid exiting thevalve 514 andmain body 512 into thebody vessel 550. - The first 516 and second 580 vessel engaging members create a
void region 590 in thevessel 550. Thevoid region 590 is excluded from the flow pattern of fluid through thevessel 550 due to the configuration of thedevice 510. Thevoid region 590 can be used for anchoring thedevice 510 to thevessel 550, such as by structural features discussed above, or by sutures or other securement means applied to the exterior of thevessel 550. Also, thevoid region 590 can be used to exclude a portion of thebody vessel 550 from fluid flow, such as a diseased portion of thevessel 550. -
FIG. 9 illustrates adelivery device 600 according to an embodiment of the invention. Thedelivery device 600 comprises a suitableelongate member 602 known to those skilled in the art. Theelongate member 602 has adistal tip 604 and defines anexternal surface 606. Amedical device 610 according to the present invention is disposed on thedistal tip 604 by passing thetip 604 through thepassageway 622 of themain body 612 of thedevice 610. Thedelivery device 600 can include asheath 608 disposed over theelongate member 602. Thesheath 608 is a hollow member that defines alumen 609 that receives theelongate member 602. Thesheath 608 can be disposed over themedical device 610 to maintain thedevice 610 in a radially compressed configuration. In this configuration, thevessel engaging member 616 is compressed between thesheath 608 and themain body 612 of themedical device 610. In this arrangement, thecatheter 600 can be navigated through a body vessel according to techniques well known in the art. Once the medical device is positioned at a point of treatment, thesheath 608 can be withdrawn to allow the medical device to change to a radially expanded configuration. Following the deployment of themedical device 610, the catheter can be withdrawn from the point of treatment, leaving themedical device 610 implanted. If themedical device 610 is a balloon expandable device, theelongate member 602 can define an inflation lumen for a balloon on which themedical device 610 is mounted, as is known in the art. - Further, the
elongate member 602 can define aguidewire lumen 607 that facilitates navigation of themember 602 through a body vessel by accommodating a previously placed guidewire. If included, theguidewire lumen 607 can extend along the entire length of theelongate member 602, or only along a portion of the length, as in a rapid exchange arrangement known in the art. A catheter according to this aspect of the invention can facilitate placement of multiple prosthetic valves in a single vessel by allowing for rapid exchange of one catheter carrying a medical device according to the invention for another without removal of a previously placed guidewire. This may be particularly desirable in prosthetic venous valve embodiments because it may be desirable to place two or more such devices in a single vessel during a single treatment. -
FIG. 10 illustrates akit 700 according to the invention. Thekit 700 comprises avalve member 702 and a plurality ofvessel engaging members 704. Thevalve member 702 comprises amain body 706 defining apassageway 708 and avalve 710 disposed in thepassageway 708 and can be any suitable main body and valve combination according to the invention, including those detailed in the context of exemplary embodiments above. Thevalve 710 is adapted to permit fluid flow through thepassageway 708 in a first direction, and substantially prevent fluid flow through thepassageway 708 in a second, opposite direction. As illustrated inFIG. 10 , thekit 700 can include a plurality ofvalve members 702. Also, thekit 700 can further include a catheter to facilitate implantation of the medical device. - Each
vessel engaging member 704 has inner 712 and outer 714 edges, and defines anaperture 716 adapted to receive avalve member 702. Also, each vessel engaging member defines a radial dimension extending between its inner 712 and outer 714 edges. - Two of the plurality of
vessel engaging members 704 have different radial dimensions extending between their respective inner 712 and outer 714 edges. The kit illustrated inFIG. 10 includes threevessel engaging members 704 having threedifferent dimensions vessel engaging members 704 of thekit 700 illustrated inFIG. 10 all haveapertures 716 of thesame diameter 724. If a plurality of valve members is included in a kit, and two valve members have main bodies of different outer diameters, the diameters of theapertures 716 could be varied in a manner similar to that of theradial dimensions - A medical device in accordance with the present invention can be made by disposing a
valve member 702 in theaperture 716 of one of the plurality ofvessel engaging members 704. Thekit 700 allows a user to assemble a medical device according to the present invention with a dimension suitable for an application of interest. For example, a clinician can assemble a medical device having avessel engaging member 704 with a dimension appropriate for implantation of the device in a vein of a patient. The dimension can be determined by determining the inner diameter of the vein at a point of treatment. - The invention also provides methods of treating a patient.
FIG. 11 provides a flow chart illustrating onemethod 800 according to the invention. In this method,step 802 comprises providing a kit according to the invention. Anotherstep 804 comprises determining an inner diameter of a body vessel at a point of treatment. This step can be accomplished by any appropriate vessel sizing technique known in the art. Anotherstep 806 comprises selecting a suitable vessel engaging member from the plurality of vessel engaging members in the kit. The selected vessel engaging member must have a dimension that is appropriate for the treatment based upon the inner diameter determined instep 804. The selection of an appropriate vessel engaging member can take into account the ability of the vessel to after its shape to accommodate an implanted article, as explained above. Anotherstep 808 comprises disposing the main body of a selected valve member from the kit in the aperture of the selected vessel engaging member to form a medical device according to the invention. Anotherstep 810 comprises implanting the assembled medical device at the point of treatment in the body vessel. Astep 812 of percutaneously delivering the medical device to the point of treatment can also be included. Step 812 can be accomplished by appropriate percutaneous techniques known in the art. - The foregoing description of exemplary embodiments of the invention includes the best mode for practicing the invention. It is intended to aid in the understanding of the invention, and not to limit the invention or its protection in any manner.
Claims (20)
1. A medical device kit, comprising:
a valve member comprising a main body defining a passageway and a valve disposed in the passageway, the valve adapted to permit fluid flow through the passageway in a first direction and to substantially prevent fluid flow through the passageway in a second, opposite direction;
a plurality of vessel engaging members, each of the plurality of vessel engaging members comprising inner and outer edges, defining an aperture adapted to receive the main body, and having a radial dimension extending from the inner edge to the outer edge;
at least one vessel engaging member of the plurality of vessel engaging members being separate from the valve member in said medical device kit; and
at least two vessel engaging members of the plurality of vessel engaging members comprising different radial dimensions;
wherein the main body of the valve member is adapted to be independently disposed in the aperture of each vessel engaging member of the plurality of vessel engaging members to form a medical device adapted for implantation in a body vessel, the medical device having an outer diameter based on the radial dimension of the vessel engaging member defining the aperture in which the main body is disposed.
2. The medical device kit of claim 1 , wherein the main body comprises a self-expanding support frame.
3. The medical device kit of claim 1 , wherein each vessel engaging member of the plurality of vessel engaging members comprises a disc-shaped member.
4. The medical device kit of claim 1 , wherein each vessel engaging member of the plurality of vessel engaging members further comprises a bioremodellable material.
5. The medical device kit of claim 1 , wherein each vessel engaging member of the plurality of vessel engaging members further comprises a hydrogel.
6. The medical device kit of claim 1 , wherein each vessel engaging member of the plurality of vessel engaging members further comprises an extracellular matrix material.
7. The medical device kit of claim 1 , wherein each vessel engaging member of the plurality of vessel engaging members further comprises small intestine submucosa.
8. The medical device of claim 1 , wherein the valve comprises a leaflet attached to the main body.
9. The medical device kit of claim 8 , wherein the leaflet is adapted to move between a first position to permit fluid flow through the passageway in the first direction and a second position to substantially prevent fluid flow through the passageway in the second, opposite direction.
10. The medical device kit of claim 8 , wherein the leaflet comprises a bioremodellable material.
11. The medical device kit of claim 8 , wherein the leaflet comprises an extracellular matrix material.
12. The medical device kit of claim 8 , wherein the leaflet comprises small intestine submucosa.
13. The medical device kit of claim 8 , wherein the valve further comprises a second leaflet attached to the main body.
14. The medical device kit of claim 10 , wherein the first and second leaflets individually move between first and second positions to cooperatively permit fluid flow through the passageway in the first direction and substantially prevent fluid flow through the passageway in the second, opposite direction.
15. The medical device kit of claim 1 , wherein at least three vessel engaging members of the plurality of vessel engaging members comprise different radial dimensions.
16. The medical device kit of claim 1 , wherein the aperture of each vessel engaging member of the plurality of vessel engaging members has an aperture diameter; and
wherein the aperture diameters of all vessel engaging members of the plurality of vessel engaging members are the same.
17. The medical device kit of claim 1 , wherein the aperture of each vessel engaging member of the plurality of vessel engaging members has an aperture diameter; and
wherein two vessel engaging members of the plurality of vessel engaging members comprise different aperture diameters.
18. The medical device kit of claim 17 , wherein the main body has a first outer diameter;
further comprising a second main body having a second outer diameter; and
wherein the first outer diameter is different than the second outer diameter.
19. A medical device kit, comprising:
a plurality of valve members, each valve member of the plurality of valve members comprising a main body having an outer diameter and defining a passageway, and a valve disposed in the passageway, the valve adapted to permit fluid flow through the passageway in a first direction and to substantially prevent fluid flow through the passageway in a second, opposite direction;
a plurality of vessel engaging members, each of the plurality of vessel engaging members comprising inner and outer edges, defining an aperture adapted to receive the main body, and having a radial dimension extending from the inner edge to the outer edge;
at least one vessel engaging member of the plurality of vessel engaging members being separate from the valve member in said medical device kit;
at least two vessel engaging members of the plurality of vessel engaging members comprising different radial dimensions; and
at least two valve members of the plurality of valve members comprising different outer diameters;
wherein the main body of each valve member is adapted to be independently disposed in the aperture of each vessel engaging member of the plurality of vessel engaging members to form a medical device adapted for implantation in a body vessel, the medical device having a device outer diameter based on the radial dimension of the vessel engaging member defining the aperture in which the main body is disposed.
20. A method of treating a patient, comprising:
providing a medical device kit according to claim 1 ;
determining an inner diameter of a body vessel of said patient at a point of treatment;
selecting a suitable vessel engaging member from the plurality of vessel engaging members based on the determined inner diameter;
disposing the main body of the valve member in the aperture of the selected vessel engaging member to form a medical device adapted for implantation in the body vessel at the point of treatment; and
implanting the medical device at the point of treatment in the body vessel.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/616,518 US20100057201A1 (en) | 2003-05-28 | 2009-11-11 | Prosthetic valve with vessel engaging member |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47391103P | 2003-05-28 | 2003-05-28 | |
US10/857,403 US7628804B2 (en) | 2003-05-28 | 2004-05-28 | Prosthetic valve with vessel engaging member |
US12/616,518 US20100057201A1 (en) | 2003-05-28 | 2009-11-11 | Prosthetic valve with vessel engaging member |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/857,403 Continuation US7628804B2 (en) | 2003-05-28 | 2004-05-28 | Prosthetic valve with vessel engaging member |
Publications (1)
Publication Number | Publication Date |
---|---|
US20100057201A1 true US20100057201A1 (en) | 2010-03-04 |
Family
ID=33490671
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/857,403 Active 2027-06-17 US7628804B2 (en) | 2003-05-28 | 2004-05-28 | Prosthetic valve with vessel engaging member |
US12/616,518 Abandoned US20100057201A1 (en) | 2003-05-28 | 2009-11-11 | Prosthetic valve with vessel engaging member |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/857,403 Active 2027-06-17 US7628804B2 (en) | 2003-05-28 | 2004-05-28 | Prosthetic valve with vessel engaging member |
Country Status (5)
Country | Link |
---|---|
US (2) | US7628804B2 (en) |
EP (1) | EP1631218B1 (en) |
AT (1) | ATE481057T1 (en) |
DE (1) | DE602004029159D1 (en) |
WO (1) | WO2004105651A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090131880A1 (en) * | 2005-05-20 | 2009-05-21 | Mayo Foundation For Medical Education And Research | Device And Methods For Reducing Cardiac Valve Regurgitation |
US20100233235A1 (en) * | 2009-02-18 | 2010-09-16 | Matheny Robert G | Compositions and methods for preventing cardiac arrhythmia |
US20110066237A1 (en) * | 2007-12-18 | 2011-03-17 | Matheny Robert G | Prosthetic tissue valve |
US8679176B2 (en) | 2007-12-18 | 2014-03-25 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valve |
US8696744B2 (en) | 2011-05-27 | 2014-04-15 | Cormatrix Cardiovascular, Inc. | Extracellular matrix material valve conduit and methods of making thereof |
US20170156863A1 (en) * | 2015-12-03 | 2017-06-08 | Medtronic Vascular, Inc. | Venous valve prostheses |
Families Citing this family (214)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
US7790192B2 (en) | 1998-08-14 | 2010-09-07 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US6692513B2 (en) | 2000-06-30 | 2004-02-17 | Viacor, Inc. | Intravascular filter with debris entrapment mechanism |
US7749245B2 (en) | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
US20020022860A1 (en) | 2000-08-18 | 2002-02-21 | Borillo Thomas E. | Expandable implant devices for filtering blood flow from atrial appendages |
US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
US7097665B2 (en) * | 2003-01-16 | 2006-08-29 | Synecor, Llc | Positioning tools and methods for implanting medical devices |
US7097659B2 (en) | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
US6752828B2 (en) | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
US8721713B2 (en) | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
US7766973B2 (en) * | 2005-01-19 | 2010-08-03 | Gi Dynamics, Inc. | Eversion resistant sleeves |
US6945957B2 (en) | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
ATE481057T1 (en) * | 2003-05-28 | 2010-10-15 | Cook Inc | VALVE PROSTHESIS WITH VESSEL FIXING DEVICE |
US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
EP2526898B1 (en) | 2003-12-23 | 2013-04-17 | Sadra Medical, Inc. | Repositionable heart valve |
US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
US7748389B2 (en) | 2003-12-23 | 2010-07-06 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US7988724B2 (en) | 2003-12-23 | 2011-08-02 | Sadra Medical, Inc. | Systems and methods for delivering a medical implant |
US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
US7824443B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Medical implant delivery and deployment tool |
US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
US8287584B2 (en) | 2005-11-14 | 2012-10-16 | Sadra Medical, Inc. | Medical implant deployment tool |
US8052749B2 (en) | 2003-12-23 | 2011-11-08 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
US7824442B2 (en) | 2003-12-23 | 2010-11-02 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
US7862610B2 (en) * | 2004-01-23 | 2011-01-04 | James Quintessenza | Bicuspid vascular valve and methods for making and implanting same |
US20050182484A1 (en) * | 2004-02-12 | 2005-08-18 | Patel Umesh H. | Hybrid grafts |
ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
US8216299B2 (en) | 2004-04-01 | 2012-07-10 | Cook Medical Technologies Llc | Method to retract a body vessel wall with remodelable material |
US20060025857A1 (en) | 2004-04-23 | 2006-02-02 | Bjarne Bergheim | Implantable prosthetic valve |
US7462191B2 (en) | 2004-06-30 | 2008-12-09 | Edwards Lifesciences Pvt, Inc. | Device and method for assisting in the implantation of a prosthetic valve |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
US8262693B2 (en) * | 2004-11-05 | 2012-09-11 | Accessclosure, Inc. | Apparatus and methods for sealing a vascular puncture |
US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
CA2588140C (en) * | 2004-11-19 | 2013-10-01 | Medtronic Inc. | Method and apparatus for treatment of cardiac valves |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
US20060173490A1 (en) | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US8663312B2 (en) * | 2005-05-27 | 2014-03-04 | Hlt, Inc. | Intravascular cuff |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US7780723B2 (en) * | 2005-06-13 | 2010-08-24 | Edwards Lifesciences Corporation | Heart valve delivery system |
US20070027528A1 (en) * | 2005-07-29 | 2007-02-01 | Cook Incorporated | Elliptical implantable device |
US7712606B2 (en) | 2005-09-13 | 2010-05-11 | Sadra Medical, Inc. | Two-part package for medical implant |
US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
WO2007038540A1 (en) | 2005-09-26 | 2007-04-05 | Medtronic, Inc. | Prosthetic cardiac and venous valves |
US8038720B2 (en) * | 2005-10-18 | 2011-10-18 | Wallace Jeffrey M | Methods and devices for intragastrointestinal prostheses |
US8167932B2 (en) | 2005-10-18 | 2012-05-01 | Edwards Lifesciences Corporation | Heart valve delivery system with valve catheter |
US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
US9078781B2 (en) | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US8075615B2 (en) | 2006-03-28 | 2011-12-13 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
US8303648B2 (en) * | 2006-04-25 | 2012-11-06 | Cook Medical Technologies Llc | Artificial venous valve containing therapeutic agent |
US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
US8348995B2 (en) | 2006-09-19 | 2013-01-08 | Medtronic Ventor Technologies, Ltd. | Axial-force fixation member for valve |
US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
EP2083901B1 (en) | 2006-10-16 | 2017-12-27 | Medtronic Ventor Technologies Ltd. | Transapical delivery system with ventriculo-arterial overflow bypass |
CN101641061B (en) | 2006-12-06 | 2013-12-18 | 美顿力科尔瓦有限责任公司 | System and method for transapical delivery of annulus anchored self-expanding valve |
US8133270B2 (en) | 2007-01-08 | 2012-03-13 | California Institute Of Technology | In-situ formation of a valve |
US7967853B2 (en) | 2007-02-05 | 2011-06-28 | Boston Scientific Scimed, Inc. | Percutaneous valve, system and method |
EP2129333B1 (en) | 2007-02-16 | 2019-04-03 | Medtronic, Inc | Replacement prosthetic heart valves |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
US8715337B2 (en) | 2007-11-09 | 2014-05-06 | Cook Medical Technologies Llc | Aortic valve stent graft |
US7846199B2 (en) | 2007-11-19 | 2010-12-07 | Cook Incorporated | Remodelable prosthetic valve |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US20110106115A1 (en) * | 2008-01-18 | 2011-05-05 | Med Institute, Inc. | Intravascular device attachment system having struts |
US9149358B2 (en) | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
EP2254512B1 (en) | 2008-01-24 | 2016-01-06 | Medtronic, Inc. | Markers for prosthetic heart valves |
WO2009094197A1 (en) | 2008-01-24 | 2009-07-30 | Medtronic, Inc. | Stents for prosthetic heart valves |
US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
US8157852B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
EP3744291B1 (en) | 2008-01-24 | 2022-11-23 | Medtronic, Inc. | Stents for prosthetic heart valves |
BR112012021347A2 (en) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
WO2009108355A1 (en) | 2008-02-28 | 2009-09-03 | Medtronic, Inc. | Prosthetic heart valve systems |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8430927B2 (en) * | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
EP2119417B2 (en) | 2008-05-16 | 2020-04-29 | Sorin Group Italia S.r.l. | Atraumatic prosthetic heart valve prosthesis |
EP4018967A1 (en) | 2008-09-15 | 2022-06-29 | Medtronic Ventor Technologies Ltd | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
WO2010042058A1 (en) * | 2008-10-10 | 2010-04-15 | Milux Holding S.A. | An improved artificial valve |
WO2010042950A2 (en) | 2008-10-10 | 2010-04-15 | Sadra Medical, Inc. | Medical devices and delivery systems for delivering medical devices |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
US8834563B2 (en) | 2008-12-23 | 2014-09-16 | Sorin Group Italia S.R.L. | Expandable prosthetic valve having anchoring appendages |
EP2246011B1 (en) | 2009-04-27 | 2014-09-03 | Sorin Group Italia S.r.l. | Prosthetic vascular conduit |
US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
IT1400327B1 (en) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT. |
BR112012029896A2 (en) | 2010-05-25 | 2017-06-20 | Jenavalve Tech Inc | prosthetic heart valve for stent graft and stent graft |
WO2012015825A2 (en) * | 2010-07-27 | 2012-02-02 | Incept, Llc | Methods and apparatus for treating neurovascular venous outflow obstruction |
WO2012030598A2 (en) | 2010-09-01 | 2012-03-08 | Medtronic Vascular Galway Limited | Prosthetic valve support structure |
CA2808673C (en) | 2010-09-10 | 2019-07-02 | Symetis Sa | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
US20120116496A1 (en) | 2010-11-05 | 2012-05-10 | Chuter Timothy A | Stent structures for use with valve replacements |
EP2486894B1 (en) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
ES2641902T3 (en) | 2011-02-14 | 2017-11-14 | Sorin Group Italia S.R.L. | Sutureless anchoring device for cardiac valve prostheses |
EP2676638B1 (en) * | 2011-02-18 | 2017-07-12 | Piolax Medical Devices, Inc. | Stent for abdominal cavity-vein shunt |
EP4119095A1 (en) | 2011-03-21 | 2023-01-18 | Cephea Valve Technologies, Inc. | Disk-based valve apparatus |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
US8998976B2 (en) | 2011-07-12 | 2015-04-07 | Boston Scientific Scimed, Inc. | Coupling system for medical devices |
DE102011108143A1 (en) * | 2011-07-21 | 2013-01-24 | Maximilian Kütting | Modular system for producing catheter-based heart valve prostheses and prosthesis for other human flap positions, has sail sheet carrying base element and anchoring elements, which is connected to base element |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
US9131926B2 (en) | 2011-11-10 | 2015-09-15 | Boston Scientific Scimed, Inc. | Direct connect flush system |
US8940014B2 (en) | 2011-11-15 | 2015-01-27 | Boston Scientific Scimed, Inc. | Bond between components of a medical device |
US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
US9277993B2 (en) | 2011-12-20 | 2016-03-08 | Boston Scientific Scimed, Inc. | Medical device delivery systems |
US9510945B2 (en) | 2011-12-20 | 2016-12-06 | Boston Scientific Scimed Inc. | Medical device handle |
EP2609893B1 (en) | 2011-12-29 | 2014-09-03 | Sorin Group Italia S.r.l. | A kit for implanting prosthetic vascular conduits |
US10172708B2 (en) | 2012-01-25 | 2019-01-08 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
WO2013120082A1 (en) | 2012-02-10 | 2013-08-15 | Kassab Ghassan S | Methods and uses of biological tissues for various stent and other medical applications |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
EP2953580A2 (en) | 2013-02-11 | 2015-12-16 | Cook Medical Technologies LLC | Expandable support frame and medical device |
JP2016512989A (en) * | 2013-03-01 | 2016-05-12 | コーマトリックス カーディオバスキュラー, インコーポレイテッドCorMatrix Cardiovascular, Inc. | Two-piece artificial valve |
US20140277388A1 (en) * | 2013-03-12 | 2014-09-18 | Aga Medical Corporation | Biocompatible foam occlusion device for self-expanding heart valves |
US10314698B2 (en) | 2013-03-12 | 2019-06-11 | St. Jude Medical, Cardiology Division, Inc. | Thermally-activated biocompatible foam occlusion device for self-expanding heart valves |
WO2014144247A1 (en) | 2013-03-15 | 2014-09-18 | Arash Kheradvar | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
WO2014179763A1 (en) | 2013-05-03 | 2014-11-06 | Medtronic Inc. | Valve delivery tool |
US9561103B2 (en) | 2013-07-17 | 2017-02-07 | Cephea Valve Technologies, Inc. | System and method for cardiac valve repair and replacement |
JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
WO2016093877A1 (en) | 2014-12-09 | 2016-06-16 | Cephea Valve Technologies, Inc. | Replacement cardiac valves and methods of use and manufacture |
WO2016115375A1 (en) | 2015-01-16 | 2016-07-21 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
WO2016126524A1 (en) | 2015-02-03 | 2016-08-11 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having tubular seal |
US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
CN107530168B (en) | 2015-05-01 | 2020-06-09 | 耶拿阀门科技股份有限公司 | Device and method with reduced pacemaker ratio in heart valve replacement |
WO2016183523A1 (en) | 2015-05-14 | 2016-11-17 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
AU2016262564B2 (en) | 2015-05-14 | 2020-11-05 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
US10335277B2 (en) | 2015-07-02 | 2019-07-02 | Boston Scientific Scimed Inc. | Adjustable nosecone |
US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
US10779940B2 (en) | 2015-09-03 | 2020-09-22 | Boston Scientific Scimed, Inc. | Medical device handle |
CA3007670A1 (en) | 2016-01-29 | 2017-08-03 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
EP3454795B1 (en) | 2016-05-13 | 2023-01-11 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system for delivery of heart valve prosthesis with introducer sheath and loading system |
US10245136B2 (en) | 2016-05-13 | 2019-04-02 | Boston Scientific Scimed Inc. | Containment vessel with implant sheathing guide |
US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
WO2017218877A1 (en) | 2016-06-17 | 2017-12-21 | Cephea Valve Technologies, Inc. | Cardiac valve delivery devices and systems |
EP3701911A1 (en) * | 2016-07-12 | 2020-09-02 | Medtronic, Inc. | Prosthetic valve for regulating fluid flow |
US10653510B2 (en) * | 2016-11-09 | 2020-05-19 | Boston Scientific Scimed, Inc. | Stent including displacement capabilities |
CN113893064A (en) | 2016-11-21 | 2022-01-07 | 内奥瓦斯克迪亚拉公司 | Methods and systems for rapid retrieval of transcatheter heart valve delivery systems |
CN109069258B (en) * | 2016-12-28 | 2020-07-03 | 先健科技(深圳)有限公司 | Lumen stent |
EP4209196A1 (en) | 2017-01-23 | 2023-07-12 | Cephea Valve Technologies, Inc. | Replacement mitral valves |
CN110621260B (en) | 2017-01-23 | 2022-11-25 | 科菲瓣膜技术有限公司 | Replacement mitral valve |
CN110392557A (en) | 2017-01-27 | 2019-10-29 | 耶拿阀门科技股份有限公司 | Heart valve simulation |
EP3634311A1 (en) | 2017-06-08 | 2020-04-15 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
CN111163729B (en) | 2017-08-01 | 2022-03-29 | 波士顿科学国际有限公司 | Medical implant locking mechanism |
EP3668449A1 (en) | 2017-08-16 | 2020-06-24 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
WO2019036810A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
KR102112820B1 (en) * | 2017-12-01 | 2020-05-19 | 주식회사 비씨엠 | A Stent |
EP3740170A1 (en) | 2018-01-19 | 2020-11-25 | Boston Scientific Scimed, Inc. | Medical device delivery system with feedback loop |
EP3740160A2 (en) | 2018-01-19 | 2020-11-25 | Boston Scientific Scimed Inc. | Inductance mode deployment sensors for transcatheter valve system |
WO2019157156A1 (en) | 2018-02-07 | 2019-08-15 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
US11439732B2 (en) | 2018-02-26 | 2022-09-13 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
WO2019222367A1 (en) | 2018-05-15 | 2019-11-21 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
US11504231B2 (en) | 2018-05-23 | 2022-11-22 | Corcym S.R.L. | Cardiac valve prosthesis |
US11241310B2 (en) | 2018-06-13 | 2022-02-08 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
AU2019374743B2 (en) | 2018-11-08 | 2022-03-03 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
US11241312B2 (en) | 2018-12-10 | 2022-02-08 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
EP3946163A4 (en) | 2019-04-01 | 2022-12-21 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
EP3952792A4 (en) | 2019-04-10 | 2023-01-04 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
CA3140925A1 (en) | 2019-05-20 | 2020-11-26 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
AU2020295566B2 (en) | 2019-06-20 | 2023-07-20 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
EP4096576A1 (en) | 2020-01-30 | 2022-12-07 | Boston Scientific Scimed Inc. | Radial adjusting self-expanding stent with anti-migration features |
Citations (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2682057A (en) * | 1951-07-24 | 1954-06-29 | Harry A Lord | Heart valve |
US3464065A (en) * | 1965-07-08 | 1969-09-02 | Surgitool Inc | Prosthetic heart valve |
US3581426A (en) * | 1969-02-17 | 1971-06-01 | Victor Comptometer Corp | Fishing reel securing device |
US4470157A (en) * | 1981-04-27 | 1984-09-11 | Love Jack W | Tricuspid prosthetic tissue heart valve |
US4626255A (en) * | 1983-09-23 | 1986-12-02 | Christian Weinhold | Heart valve bioprothesis |
US4662885A (en) * | 1985-09-03 | 1987-05-05 | Becton, Dickinson And Company | Percutaneously deliverable intravascular filter prosthesis |
US4680031A (en) * | 1982-11-29 | 1987-07-14 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US4680131A (en) * | 1983-04-20 | 1987-07-14 | The Proctor & Gamble Company | Detergent compositions |
US4705516A (en) * | 1983-04-20 | 1987-11-10 | Barone Hector D | Setting for a cardiac valve |
US4856510A (en) * | 1988-04-06 | 1989-08-15 | Kowalewski Ryszard J | Tracheal tube inflator |
US5103817A (en) * | 1990-07-20 | 1992-04-14 | Xomed-Treace Inc. | Automatic dye dispersant for endotracheal tubes and catheters |
US5322062A (en) * | 1993-04-08 | 1994-06-21 | Servas Francis M | Non-inflatable sealing cuff for tracheal tube and other cannula |
US5326371A (en) * | 1991-01-24 | 1994-07-05 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
US5713953A (en) * | 1991-05-24 | 1998-02-03 | Sorin Biomedica Cardio S.P.A. | Cardiac valve prosthesis particularly for replacement of the aortic valve |
US5855602A (en) * | 1996-09-09 | 1999-01-05 | Shelhigh, Inc. | Heart valve prosthesis |
US5891195A (en) * | 1996-05-24 | 1999-04-06 | Sulzer Carbomedics Inc. | Combined prosthetic aortic heart valve and vascular graft with sealed sewing ring |
US5937861A (en) * | 1995-06-07 | 1999-08-17 | Augustine Medical, Inc. | Tracheal tube with self-supporting tracheal tube cuff |
US5947995A (en) * | 1997-06-06 | 1999-09-07 | Samuels; Shaun Lawrence Wilkie | Method and apparatus for removing blood clots and other objects |
US6042607A (en) * | 1996-02-23 | 2000-03-28 | Cardiovascular Technologies Llc | Means and method of replacing a heart valve in a minimally invasive manner |
US6106550A (en) * | 1998-07-10 | 2000-08-22 | Sulzer Carbomedics Inc. | Implantable attaching ring |
US6312465B1 (en) * | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
US6371983B1 (en) * | 1999-10-04 | 2002-04-16 | Ernest Lane | Bioprosthetic heart valve |
US6494909B2 (en) * | 2000-12-01 | 2002-12-17 | Prodesco, Inc. | Endovascular valve |
US6506197B1 (en) * | 2000-11-15 | 2003-01-14 | Ethicon, Inc. | Surgical method for affixing a valve to a heart using a looped suture combination |
US6508833B2 (en) * | 1998-06-02 | 2003-01-21 | Cook Incorporated | Multiple-sided intraluminal medical device |
US20030078617A1 (en) * | 2001-07-16 | 2003-04-24 | Schwartz Herbert E. | Unitary surgical device and method |
US20040015232A1 (en) * | 2002-07-16 | 2004-01-22 | Medtronic, Inc. | Suturing rings for implantable heart valve prosthesis |
US6733525B2 (en) * | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US20040204692A1 (en) * | 2003-04-11 | 2004-10-14 | Kenneth Eliasen | Implantable vascular access device |
US20040243222A1 (en) * | 2003-05-19 | 2004-12-02 | Osborne Thomas A. | Implantable medical device with constrained expansion |
US20040254636A1 (en) * | 2003-05-28 | 2004-12-16 | Flagle Jacob A. | Prosthetic valve with vessel engaging member |
US20050033398A1 (en) * | 2001-07-31 | 2005-02-10 | Jacques Seguin | Assembly for setting a valve prosthesis in a corporeal duct |
US20050165479A1 (en) * | 2004-01-26 | 2005-07-28 | Drews Michael J. | Heart valve assembly and methods for using them |
US7041132B2 (en) * | 2002-08-16 | 2006-05-09 | 3F Therapeutics, Inc, | Percutaneously delivered heart valve and delivery means thereof |
US20070198097A1 (en) * | 2003-12-23 | 2007-08-23 | Laboratoires Perouse | Kit For Implanting In A Duct |
US20070255394A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Method and apparatus for cardiac valve replacement |
US7981153B2 (en) * | 2002-12-20 | 2011-07-19 | Medtronic, Inc. | Biologically implantable prosthesis methods of using |
US8021421B2 (en) * | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US20120165925A1 (en) * | 1999-05-25 | 2012-06-28 | Daidalos Solutions B.V. | Fixing device, in particular for fixing to vascular wall tissue |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6271196A (en) * | 1995-06-07 | 1996-12-30 | St. Jude Medical Inc. | Direct suture orifice for mechanical heart valve |
EP1584307A3 (en) | 1999-04-23 | 2005-10-19 | St.Jude Medical ATG, Inc. | Artificial heart valve with attachment fingers |
AU6786400A (en) | 1999-08-16 | 2001-03-13 | Citron Limited | Autologous tissue suture ring used in heart valve implantation |
US6679264B1 (en) | 2000-03-04 | 2004-01-20 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
JP3966016B2 (en) | 2002-02-26 | 2007-08-29 | 株式会社デンソー | Clamp circuit |
JP4624984B2 (en) * | 2003-03-12 | 2011-02-02 | クック インコーポレイテッド | Artificial valve that allows backflow |
-
2004
- 2004-05-28 AT AT04753762T patent/ATE481057T1/en not_active IP Right Cessation
- 2004-05-28 EP EP04753762A patent/EP1631218B1/en active Active
- 2004-05-28 DE DE602004029159T patent/DE602004029159D1/de active Active
- 2004-05-28 US US10/857,403 patent/US7628804B2/en active Active
- 2004-05-28 WO PCT/US2004/017002 patent/WO2004105651A1/en active Application Filing
-
2009
- 2009-11-11 US US12/616,518 patent/US20100057201A1/en not_active Abandoned
Patent Citations (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2682057A (en) * | 1951-07-24 | 1954-06-29 | Harry A Lord | Heart valve |
US3464065A (en) * | 1965-07-08 | 1969-09-02 | Surgitool Inc | Prosthetic heart valve |
US3581426A (en) * | 1969-02-17 | 1971-06-01 | Victor Comptometer Corp | Fishing reel securing device |
US4470157A (en) * | 1981-04-27 | 1984-09-11 | Love Jack W | Tricuspid prosthetic tissue heart valve |
US4680031A (en) * | 1982-11-29 | 1987-07-14 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US4680131A (en) * | 1983-04-20 | 1987-07-14 | The Proctor & Gamble Company | Detergent compositions |
US4705516A (en) * | 1983-04-20 | 1987-11-10 | Barone Hector D | Setting for a cardiac valve |
US4626255A (en) * | 1983-09-23 | 1986-12-02 | Christian Weinhold | Heart valve bioprothesis |
US4662885A (en) * | 1985-09-03 | 1987-05-05 | Becton, Dickinson And Company | Percutaneously deliverable intravascular filter prosthesis |
US4856510A (en) * | 1988-04-06 | 1989-08-15 | Kowalewski Ryszard J | Tracheal tube inflator |
US5103817A (en) * | 1990-07-20 | 1992-04-14 | Xomed-Treace Inc. | Automatic dye dispersant for endotracheal tubes and catheters |
US5326371A (en) * | 1991-01-24 | 1994-07-05 | Autogenics | Rapid assembly, concentric mating stent, tissue heart valve with enhanced clamping and tissue alignment |
US5713953A (en) * | 1991-05-24 | 1998-02-03 | Sorin Biomedica Cardio S.P.A. | Cardiac valve prosthesis particularly for replacement of the aortic valve |
US5322062A (en) * | 1993-04-08 | 1994-06-21 | Servas Francis M | Non-inflatable sealing cuff for tracheal tube and other cannula |
US5937861A (en) * | 1995-06-07 | 1999-08-17 | Augustine Medical, Inc. | Tracheal tube with self-supporting tracheal tube cuff |
US6042607A (en) * | 1996-02-23 | 2000-03-28 | Cardiovascular Technologies Llc | Means and method of replacing a heart valve in a minimally invasive manner |
US5891195A (en) * | 1996-05-24 | 1999-04-06 | Sulzer Carbomedics Inc. | Combined prosthetic aortic heart valve and vascular graft with sealed sewing ring |
US5855602A (en) * | 1996-09-09 | 1999-01-05 | Shelhigh, Inc. | Heart valve prosthesis |
US5947995A (en) * | 1997-06-06 | 1999-09-07 | Samuels; Shaun Lawrence Wilkie | Method and apparatus for removing blood clots and other objects |
US6508833B2 (en) * | 1998-06-02 | 2003-01-21 | Cook Incorporated | Multiple-sided intraluminal medical device |
US6106550A (en) * | 1998-07-10 | 2000-08-22 | Sulzer Carbomedics Inc. | Implantable attaching ring |
US20120165925A1 (en) * | 1999-05-25 | 2012-06-28 | Daidalos Solutions B.V. | Fixing device, in particular for fixing to vascular wall tissue |
US6312465B1 (en) * | 1999-07-23 | 2001-11-06 | Sulzer Carbomedics Inc. | Heart valve prosthesis with a resiliently deformable retaining member |
US6371983B1 (en) * | 1999-10-04 | 2002-04-16 | Ernest Lane | Bioprosthetic heart valve |
US6506197B1 (en) * | 2000-11-15 | 2003-01-14 | Ethicon, Inc. | Surgical method for affixing a valve to a heart using a looped suture combination |
US6494909B2 (en) * | 2000-12-01 | 2002-12-17 | Prodesco, Inc. | Endovascular valve |
US6733525B2 (en) * | 2001-03-23 | 2004-05-11 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of use |
US20030078617A1 (en) * | 2001-07-16 | 2003-04-24 | Schwartz Herbert E. | Unitary surgical device and method |
US20050033398A1 (en) * | 2001-07-31 | 2005-02-10 | Jacques Seguin | Assembly for setting a valve prosthesis in a corporeal duct |
US7172625B2 (en) * | 2002-07-16 | 2007-02-06 | Medtronic, Inc. | Suturing rings for implantable heart valve prostheses |
US20040015232A1 (en) * | 2002-07-16 | 2004-01-22 | Medtronic, Inc. | Suturing rings for implantable heart valve prosthesis |
US7041132B2 (en) * | 2002-08-16 | 2006-05-09 | 3F Therapeutics, Inc, | Percutaneously delivered heart valve and delivery means thereof |
US7981153B2 (en) * | 2002-12-20 | 2011-07-19 | Medtronic, Inc. | Biologically implantable prosthesis methods of using |
US20040204692A1 (en) * | 2003-04-11 | 2004-10-14 | Kenneth Eliasen | Implantable vascular access device |
US20040243222A1 (en) * | 2003-05-19 | 2004-12-02 | Osborne Thomas A. | Implantable medical device with constrained expansion |
US20040254636A1 (en) * | 2003-05-28 | 2004-12-16 | Flagle Jacob A. | Prosthetic valve with vessel engaging member |
US7628804B2 (en) * | 2003-05-28 | 2009-12-08 | Cook Incorporated | Prosthetic valve with vessel engaging member |
US8021421B2 (en) * | 2003-08-22 | 2011-09-20 | Medtronic, Inc. | Prosthesis heart valve fixturing device |
US20070198097A1 (en) * | 2003-12-23 | 2007-08-23 | Laboratoires Perouse | Kit For Implanting In A Duct |
US20050165479A1 (en) * | 2004-01-26 | 2005-07-28 | Drews Michael J. | Heart valve assembly and methods for using them |
US20070255394A1 (en) * | 2006-04-28 | 2007-11-01 | Medtronic, Inc. | Method and apparatus for cardiac valve replacement |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7854762B2 (en) * | 2005-05-20 | 2010-12-21 | Mayo Foundation For Medical Education And Research | Devices and methods for reducing cardiac valve regurgitation |
US20090131880A1 (en) * | 2005-05-20 | 2009-05-21 | Mayo Foundation For Medical Education And Research | Device And Methods For Reducing Cardiac Valve Regurgitation |
US8679176B2 (en) | 2007-12-18 | 2014-03-25 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valve |
US20110066237A1 (en) * | 2007-12-18 | 2011-03-17 | Matheny Robert G | Prosthetic tissue valve |
US8257434B2 (en) | 2007-12-18 | 2012-09-04 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valve |
US8449607B2 (en) | 2007-12-18 | 2013-05-28 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valve |
US20100233235A1 (en) * | 2009-02-18 | 2010-09-16 | Matheny Robert G | Compositions and methods for preventing cardiac arrhythmia |
US8980296B2 (en) | 2009-02-18 | 2015-03-17 | Cormatrix Cardiovascular, Inc. | Compositions and methods for preventing cardiac arrhythmia |
US8696744B2 (en) | 2011-05-27 | 2014-04-15 | Cormatrix Cardiovascular, Inc. | Extracellular matrix material valve conduit and methods of making thereof |
US8845719B2 (en) | 2011-05-27 | 2014-09-30 | Cormatrix Cardiovascular, Inc | Extracellular matrix material conduits and methods of making and using same |
US20170156863A1 (en) * | 2015-12-03 | 2017-06-08 | Medtronic Vascular, Inc. | Venous valve prostheses |
US10143554B2 (en) * | 2015-12-03 | 2018-12-04 | Medtronic Vascular, Inc. | Venous valve prostheses |
US10973640B2 (en) | 2015-12-03 | 2021-04-13 | Medtronic Vascular, Inc. | Venous valve prostheses |
US11684476B2 (en) | 2015-12-03 | 2023-06-27 | Medtronic Vascular, Inc. | Venous valve prostheses |
Also Published As
Publication number | Publication date |
---|---|
US7628804B2 (en) | 2009-12-08 |
ATE481057T1 (en) | 2010-10-15 |
DE602004029159D1 (en) | 2010-10-28 |
EP1631218A1 (en) | 2006-03-08 |
EP1631218B1 (en) | 2010-09-15 |
WO2004105651A1 (en) | 2004-12-09 |
US20040254636A1 (en) | 2004-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7628804B2 (en) | Prosthetic valve with vessel engaging member | |
US7563276B2 (en) | Intraluminal medical device with cannula for controlled retrograde flow | |
US11717408B2 (en) | Implantable valve device | |
US20100114300A1 (en) | Medical device with leak path | |
US7128759B2 (en) | Implantable medical device with constrained expansion | |
JP4589395B2 (en) | Prosthetic valve with holes | |
US7402171B2 (en) | Prosthetic valve that permits retrograde flow | |
CA2401996C (en) | Bulbous valve and stent for treating vascular reflux | |
CN102245129B (en) | Repositionable endoluminal support structure and its applications | |
US20100023114A1 (en) | Valve device with biased leaflets | |
US20080312735A1 (en) | Combination valve and stent for treating vascular reflux | |
AU2017204546A1 (en) | Prosthetic insert for improving heart valve function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |